Congress of the International Society on Thrombosis and Haemostasis

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

M
M Karimipoor	-	Genotyping of Hemophilia B in Iran by SSCP and Sequencing
M Lak	-	Genotyping of Hemophilia B in Iran by SSCP and Sequencing
M Clerici	-	The Detection of Lupus Anticoagulants in Hemophiliacs: The Need for Different Assay Systems
M Musso	-	Proposal of Immunotolerance Induction in Haemophiliacs A with Inhibitors Undergoing to Pressing Elective Surgery by Using FVIII/vWF-enriched Pure Plasmaderivates
M Colombo	-	Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients
M Chandy	-	Thirty Novel Mutations in the Factor VIII Gene of Indian Patients with Haemophilia A
M Morelli B	-	Evaluation of the New ACL TOP Coagulation Analyser from IL
M.-Smith M	-	A Mechanism of Impaired Platelet Response to ADP Stimulation in the CLIC1 Knockout Mice
Ma T	-	Elevated Plasma Levels of High Sensitivity C-Reactive Protein in Patients with Coronary Bridge and No Significant Coronary Stenosis
Ma B	-	Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China
Ma DDF	-	The Activation of Intracoronary Monocytes and Platelets Correlates with Cardiac Enzyme Levels in Patients Undergoing Coronary Artery Stenting
Ma Q	-	Biochemical and Pharmacological Equivalence of Generic Versions of Low Molecular Weight Heparins. A Comparative Study with Innovator Products
Ma DDF	-	Methodological Issues Which May Influence the Detection, Quantitation and Functional Assessment of Platelet-Derived Microparticles
Ma D	-	NF-kB Activation Mediates Deep Vein Thrombosis: Inhibition by the NF-kB Inhibitor Andrographolide and Its Derivatives
Ma YY	-	The Expression of Recombinant Adeno-Associated Virus/Human Coagulant Factor IX Gene in Human/Rat Gut Epithelial Cells
Ma DDF	-	Prothrombotic Potential of Sclerosants: In Vitro Effects on Coagulation, Red cells and Platelets
	-	Procoagulant Phospholipid Activity Associates Not Only with Free Microparticles, But with Platelets and/or Microparticles Complexed to Erythrocytes and Leukocytes
Ma Q	-	Comparative Antithrombotic Effects of an Ultra Low Molecular Wight Heparin (Oligo H) and Enoxaparin in Animal Models of Arterial Thrombosis
	-	Effect of 1,6-Anhydro Bicyclic Ring Structure on the Pharmacokinetic and Pharmacodynamic Behavior of Low Molecular Weight Heparin
Maakaroun² M	-	Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study
Maas C	-	Factor XII (fXII) Is Activated by Unfolded Proteins on the Surface of Negatively Charged Substances, Rather than by These Surfaces Themselves
	-	Binding of Amyloid to the Fibronectin Type I Domain of tPA And Factor XII Induces Activation of the Fibrinolytic System and the Contact System
Maasland H	-	Safe Exclusion of Deep Vein Thrombosis (DVT) by a Normal Rapid ELISA D-Dimeer (<500 Ng/Ml) and by the Combination of a Negative Compression Ultrasonography and a D-Dimer of <1000 Ng/Ml in 1330 Consecutive Outpatients with Suspected DVT in the Primary Care Setting
Maayan-Metzger A	-	Platelet Function of Preterm and Full Term Newborns Tested by The Cone and Plate(let) Analyzer Correlates with Gestational Age
Macarone PN	-	Cardiovascular Risk Factors and the Risk of Venous Thromboembolism
Macarone	-	Assessing Efficacy and Safety of Recombinant Activated Factor VII in Patients with Platelet Functional Abnormalities Undergoing Surgical Procedures
Macarone Palmieri N	-	Recurrent Arterial Thrombosis in Patients Taking Aspirin
	-	Any Relationship Between Inherited Thrombophilia and Bleeding Phenotype or Vascular Disease in Patients with Hemophilia and von Willebrand Disease?
	-	Clinical and Pharmacoeconomic Impact of Secondary Prophylaxis in Young-Adults with Severe Hemophilia A
Macarone Palmieri N	-	Genetic and Acquired Risk Factors in Patients with Portal and Mesenteric Venous Thrombosis
Macaulay E	-	The Effects of Surgery on Platelet and Endothelial Function in Patients with Peripheral Arterial Disease and Severe Limb Ischaemia
Macaulay IC	-	Functional Differences in the Response of Platelets to Collagen That Are Linked to Glycoprotein VI Genotype Are Also Associated with Differences in Platelet Gene Expression Profiles
Macaulay E	-	The Effects of Isometric and Treadmill Exercise on Platelet and Endothelial Function in Patients with Intermittent Claudication
MacCallum PK	-	Persistent Hypercoagulability and Risk of Cancer in Older Men
	-	Fibrinogen May Predict Death from Cancer in Men with Lower Extremity Arterial Disease
	-	Management of Anticoagulated Patients Undergoing Dental Treatment
	-	Risk Factors for Central Retinal Vein Occlusion
MacCallum P	-	Satisfaction and Safety of Two Domiciliary Anticoagulation Services for Mobility-impaired Patients: Preliminary Trial Findings
Macchi C	-	Inflammatory Markers are Associated with the Abdominal Aortic Diameter
MacCluer JW	-	A Quantitative Trait Locus on Chromosome 12q14.1 Influences Plasminogen Levels in the San Antonio Heart Family Study (SAFHS)
MacGillivray R	-	Platelets Provide Factor IX (FIX) and Factor X (FX) to Support Dilute Tissue-factor Dependent Coagulation
MacGillivray RTA	-	The Effect of Factor Va on Prothrombin-Membrane Binding
	-	Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B
MacGregor I	-	A New Double Virus Inactivated 4-Factor Prothrombin Complex Concentrate (4F PCC)
MacGregor D	-	Preliminary Results of a Cross-Sectional Study of Mild Hemophilia A in Newfoundland and Labrador, Canada
Macgregor D	-	Molecular Defect of Factor XIII A Subunit in Newfoundland Families with Factor XIII A Subunit Deficiency
MacGregor I	-	Plasma Prion Protein (PrP^C) in Patients with Vascular Diseases
Mach F	-	Effect of Statins on Clopidogrel Platelet Inhibition as Measured by ADP Induced Platelet Aggregation and RPFA-P2Y12 (Accumetrics) in Healthy Volunteers
	-	Atherosclerosis in LDLR Knock-Out Mice Immunized with b2GP1: Effect of High Cholesterol Diet and Pravastatin Supplementation
Machac S	-	Prevalence of Inherited Thrombophilia in Severe OHSS
Machado TF	-	Molecular Analysis of Two Unrelated Patients with Bernard-Soulier Syndrome – Identification of Novel Mutation in Glycoprotein Ib Alpha Gene
	-	Effects of Warfarin Administration on in vivo Revascularization in a Rat Model of Hindlimb Ischemia
Machado R	-	Homozygous Protein C Deficiency: A Case Report of Neonatal Purpura Fulminans Treated with Activated Protein C Concentrate and High dose of Enoxaparin
Machesky LM	-	Evaluation of the Roles of Rac1 and Rac2 in Lamellipodia and Aggregate Formation on Collagen Under Flow
Machiah DK	-	The Pharmacogenetics and Inhibitor Risk (PIR) Study: Do the Multiple Forms of Wildtype Factor (F)VIII Contribute to the Development of Anti-FVIII Antibodies in Hemophilia a Patients during Coagulation Factor Replacement Therapy?
Machin SJ	-	ADAMTS13 Gene Mutations and Polymorphisms in Acquired Thrombotic Thrombocytopenic Purpura (TTP) Patients
Machin S	-	Plasma Prion Protein (PrP^C) in Patients with Vascular Diseases
	-	Successful Management of Pregnancy in Women with a History of Thrombotic Thrombocytopenic Purpura: A Role for ADAMTS 13 Monitoring
	-	Use of Rituximab in Acute Refractory Thrombotic Thrombocytopenic Purpura
Machin SJ	-	A Randomised Control Trial of Patient Self-Management of Oral Anticoagulation Compared with Patient Self-Testing
	-	Implementation of a Telematic Homecare Platform for Oral anticoagulant Management
Machin S	-	Platelet Calcium Mobilisation by Recombinant Factor VIIa Is Partially Mediated by Tissue Factor-Dependent Thrombin Generation
Machin SJ	-	Lupus Anticoagulant Testing Using a Dilute Prothrombin Time with Confirm Procedure
Machin S	-	Treatment of HIV Associated Thrombotic Thrombocytopenic Purpura-Importance of Prompt Diagnosis
Machin M	-	Von Willebrand Factor-Mediated Platelet Adhesion in Flowing Blood is Influenced by Hematocrit
Machin S	-	The Sensitive Detection of Antibodies to von Willebrand Factor Cleaving Protease (ADAMTS-13)
	-	Characterisation of Anti-ADAMTS13 Autoantibodies from a Patient with Thrombotic Thrombocytopenic Purpura (TTP)
Machovich R	-	Modulation of Fibrinolysis by Some Components Present in Arterial Thrombus
MacKenzie M	-	Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels
Mackett N	-	The Application of New Diagnostic Guidelines in Type 1 von Willebrand Disease to Patients Previously Diagnosed Under the UK 1995 Guidelines. A Single Centre Paediatric Experience
Mackie IJ	-	Lupus Anticoagulant Testing Using a Dilute Prothrombin Time with Confirm Procedure
Mackie I	-	Platelet Calcium Mobilisation by Recombinant Factor VIIa Is Partially Mediated by Tissue Factor-Dependent Thrombin Generation
Mackie IJ	-	Implementation of a Telematic Homecare Platform for Oral anticoagulant Management
Mackie I	-	Six Children with Congenital Deficiency of ADAMTS-13: Clinical Features and Treatment
	-	The Sensitive Detection of Antibodies to von Willebrand Factor Cleaving Protease (ADAMTS-13)
	-	Characterisation of Anti-ADAMTS13 Autoantibodies from a Patient with Thrombotic Thrombocytopenic Purpura (TTP)
	-	Investigation of Relationship between ADAMTS-13, Von Willebrand Factor Antigen and Collagen-Binding Activity in Patients with Type 1 Von Willebrand Disease
	-	Treatment of HIV Associated Thrombotic Thrombocytopenic Purpura-Importance of Prompt Diagnosis
Mackie IJ	-	Evaluation of Fluorogenic Substrates for the Monitoring of Thrombin Generation
Mackie I	-	Use of Rituximab in Acute Refractory Thrombotic Thrombocytopenic Purpura
Mackie IJ	-	A Randomised Control Trial of Patient Self-Management of Oral Anticoagulation Compared with Patient Self-Testing
Mackie I	-	Successful Management of Pregnancy in Women with a History of Thrombotic Thrombocytopenic Purpura: A Role for ADAMTS 13 Monitoring
	-	Plasma Prion Protein (PrP^C) in Patients with Vascular Diseases
	-	Investigation of Relationship of von Willebrand Factor Antigen Clearance with ADAMTS-13 Activity and Tyr1584Cys Polymorphism in Type 1 von Willebrand Disease
Mackie IJ	-	ADAMTS13 Gene Mutations and Polymorphisms in Acquired Thrombotic Thrombocytopenic Purpura (TTP) Patients
MacKinnon B	-	Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial
	-	Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH)
Mackman N	-	Egr-1: A Key Mediator of Oscillatory Shear Stress Induction of Tissue Factor Promoter
Mackman N	-	Tissue Factor in Hemostasis and Thrombosis
Mackway-Jones K	-	Retrospective Calculation of the Modified Wells' Clinical Probability of Pulmonary Embolism: Agreement with Prospective Scoring
	-	PIOPED Ventilation-perfusion Scan Reporting: The Inter-observer Variation
	-	Outreach Anticoagulation Project For Injecting Drug Users With Deep Vein Thrombosis: A Randomised Controlled Trial
	-	Anaemia in Injecting Drug Users (IDU) with Deep Vein Thrombosis (DVT)
	-	Management of Injecting Drug Users (IDU) with Deep Vein Thrombosis (DVT): A Delphi Study
Maclean RM	-	Clinical Use of Protamine for the Emergency Reversal of Anticoagulation with Low Molecular Weight Heparin (LMWH)
	-	Haemoperitoneum Associated with Ovulation in Women with Autosomal Recessive Bleeding Disorders
MacMahon S	-	Associations of Inflammatory and Haemostatic Variables with the Risk of Recurrent Stroke
Maconi M	-	Resistance to Activated Proteine C (aPCR) in Subjects ‘Negative’ for Factor V Leiden (FVL) and ‘Positive’ for Antiphospholipid Antibodies (APL)
Madar Z	-	Angiotensin Receptor 2 Over-Expression in Bradykinin B2 Receptor Knockout Mice Produces Thromboprotection
Maddenini J	-	Antithrombotic Mechanism of Action of BAY 59-7939 – a Novel, Oral, Direct Factor Xa Inhibitor
	-	Comparison of the Anticoagulant Properties of BAY 59-7939 – An Oral, Direct Factor Xa Inhibitor – with Fondaparinux and Enoxaparin
Maddineni J	-	Development of Non-Anticoagulant Derivatives of K5-Derived Sulfaminoheparosans and Investigation of Their Non-Anticoagulant Effects
	-	Biochemical and Pharmacologic Profiling of a Novel Dual Acting Antithrombin Agent with Antiprotease and Antiplatelet Actions
	-	Differential Digestion of LMWHs By Heparinase-I and Heparinase-II: Drug Developmental Implications
	-	Comparative Antithrombotic Effects of an Ultra Low Molecular Wight Heparin (Oligo H) and Enoxaparin in Animal Models of Arterial Thrombosis
	-	Proteomic Profiles in Critically Ill Emergency Department Patients, Utilizing ProteinChip Array Technology
	-	Tissue Factor, Thrombomodulin and P-Selectin Levels Are Increased in End Stage Renal Disease
	-	Antithrombotic Effects of Bacterial K5-Derived Sulfaminoheparosans in a Jugular Vein Crush Model of Thrombosis in Rats
	-	Inhibition of Tissue Factor Mediated Protease Activation by Mucosopolysaccharide Polysulfate. Results from Studies on Proteinchip Array Using SELDI-MS
	-	Functional Decrease in Thrombin Activatable fibrinolytic Inhibitor by Anticoagulant Drugs: A Possible Explanation for the Observed Profibrinolytic Actions
	-	Tissue Factor Mediated Activation of Prothrombin Complex Concentrates and Its Inhibition by Anti-Thrombin Drugs
	-	Fish Skins as a Source of Heparin-Like GAGs
	-	Sulfaminoheparosan Mediated Inhibition of Tissue Factor Induced Generation of Proteases as Studied by Protein Chip Array Analysis
	-	Biochemical and Pharmacological Equivalence of Generic Versions of Low Molecular Weight Heparins. A Comparative Study with Innovator Products
	-	Protamine Sulfate Is Capable of Neutralizing Bacterial Core Polysaccharide Derived Sulfaminoheparosans
Maddox KM	-	Identification and Characterization of Novel Members of the Calcium and Integrin Binding Protein Family
Madeo D	-	Hereditary Protein C Deficiency: Prevalence and Risk of Venous Thromboembolism in the General Population. Preliminary Results from the Vita Study
Mäder G	-	A Second Swiss Family with Upshaw-Schulman Syndrome (Hereditary Thrombotic Thrombocytopenic Purpura, TTP): Clinical Course and Molecular Findings
Madhani M	-	Management of Anticoagulated Patients Undergoing Dental Treatment
Madoiwa S	-	Intervention of Plasminogen Activator Inhibitor-1 in Nasal Allergy
	-	Phenotype Correction of Hemophilia A Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene
	-	Aspirin Resistance Detected with Aggregometry Can Not Be Explained by Failure to Suppress Cyclooxygenase Activity: Possible Involvement of Other Signaling Pathway(s) in Cardiovascular Events of Aspirin-treated Patients
	-	Phenotype Correction of Hemophilia a Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene
Madonna R	-	Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue
	-	MAP-Kinase/NF-kB-Dependent Endothelial Activation and Inhibition of PI3-kinase/Nitric Oxide Are Both Involved in Pro-Atherogenic Effects of Insulin – A Link to the Pathogenesis of Accelerated Atherosclerosis in Diabetes
	-	Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue
Madsen EM	-	Anticoagulation for Patients with Inferior Vena Cava Filters
Madsen J	-	New Scintigraphic Method for Imaging of Gastro-intestinal Bleeding: Preliminary Results from Ex Vivo Studies in Rabbits
Maeda N	-	Effective Inhibition of Platelet Aggregation and Release Reaction with Lack of Effect on Shape Change by CS-747 (Prasugrel, LY640315) and Its Active Metabolite
	-	Decreased Protein C Activation and Accelerated Thrombosis in Human Thrombomodulin Knockin Mice
Maekawa A	-	Thrombospondin as a Regulator of von Willebrand Factor Multimer Size
Maemura K	-	Circadian Oscillation of Thrombomodulin Gene Expression in Peripheral Tissues
Maerz W	-	Factor VIII Activity and Antigen, VWF and ABO-Genotype Are Not Associated with Coronary Heart Disease
Maffei FH	-	Systematic Review of Risk Factors for Venous Thromboembolism in Hospitalized Medical Patients and Recommendations for Prophylaxis Implementation by a Multidisciplinary Group
Magari Y	-	Measuring Concentration of Soluble Fibrinogen and Fibronectin Complexes (FG-FN) in Patient' Plasma with Various Diseases Using Two-Step Sandwich ELISA Method
Magdeleyns E	-	Platelet Derived Microparticles in Blood Bank Products Do Not Expose Functionally Active Tissue Factor But Are Highly Procoagulant
Mager J	-	TECHNOTHROMBIN^® TGA a Novel Thrombin Generation Assay Suitable for the New Routine Coagulation Analyzer Ceveron^® Alpha
	-	Characterization and Thrombogenicity of Microparticles Derived from Endothelial Cells, Smooth Muscle Cells, and Monocytes as Measured By a Novel Thrombin Generation Assay (TECHNOTHROMBIN^® TGA)
Maggiano N	-	Platelets Morphological and Functional Characterisation in a Novel Case of Grey Platelet Syndrome: Defective Response to Thrombin, PAR1-AP And PAR4-AP and Correlation with Alpha-Granules Content in the Patient and Four Relatives
Maghenzani M	-	Cerebral Sinovenous Thrombosis during L-Asparaginase Treatment
Maglaras G	-	Assessing Acquired and Inherited Factors in Cases of Idiopathic and Secondary Pulmonary Embolism
Magnani HN	-	Treatment of 51 Pregnancies with Danaparoid Because of Heparin Intolerance
	-	A Historical Comparison of Danaparoid (with or without Coumarin) Versus Ancrod (with or without Coumarin), or Coumarin Alone, for the Treatment of Heparin-Induced Thrombocytopenia (HIT): Evidence That Treatment Experience Can Influence Choice of Anticoagulant Rather Than Approval Status
Magnani H	-	Heparin-Induced Thrombocytopenia (HIT) and Danaparoid (Orgaran^®): Review of 1479 Reported Clinical Outcomes of Patients Treated Between 1981 and 2004
Mahé I	-	The Predictive Value of D-Dimers on the Occurrence of Thromboembolic Events and Death: A Prospective Multicentric Study
	-	Interaction between Paracetamol and Warfarin: A Double-Blind Placebo-Controlled Randomised Study
Mahagney A	-	Clinical Features of Cerebral Venous Thrombosis
Mahaney MC	-	A Quantitative Trait Locus on Chromosome 12q14.1 Influences Plasminogen Levels in the San Antonio Heart Family Study (SAFHS)
Mahdi F	-	Prolylcarboxypeptidase (PRCP): Characterization of Truncated Forms
	-	Prolylcarboxypeptidase Activates Plasma Prekallikrein on Transfected CHO Cells
	-	Angiotensin Receptor 2 Over-Expression in Bradykinin B2 Receptor Knockout Mice Produces Thromboprotection
Mahé I	-	We Still Need to Organize French Anticoagulation Clinics
	-	A Multi-Rule Expert System to Manage OAT in Most Real-Life Clinical Situations
Mahesh S	-	Anticoagulation for Patients with Inferior Vena Cava Filters
Mahnel R	-	Effect of Beer, Dealcoholized Beer and Ethanol Consumption on Hemostasis in Humans
Mahon CM	-	The Impact of Acquired Thrombophilia on Maternal and Fetal Wellbeing in a Low-risk Population
Mai G	-	Isolation, Characterization and Angiogenic Potential of Human Mesenchymal Stem Cell-Derived Endothelial-Like Progenitor Cells
Mainwaring CJ	-	Intravenous DDAVP Associated Reduction in Fibrinogen – Implications for Patients with Von Willebrand's Disease or Haemophilia A with Borderline Fibrinogen Levels Requiring Invasive Procedures
Mainwaring J	-	Effect on the Tissue Factor Pathway of Cessation of Warfarin Anticoagulant Therapy
	-	Influence of the Tissue Factor Pathway on Initiation of Warfarin Anticoagulant Therapy
	-	Introduction of Thromboelastography for Monitoring Haemostatic Function during Pseudomyxoma Peritonei Surgery
Maio H	-	Factor VIII Expression Induces ER Stress Apoptosis In Cultured Cells and in Mice
Mairuhu ATA	-	Coagulation Disorders in Severe leptospirosis in Indonesia
	-	The Role of PAI-1 Deficiency and a Reduced Capacity to Generate Activated Protein C on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia
	-	Naturally Occurring Acute Viral Respiratory Tract Infections in Elderly Patient Results in Increased von Willebrand and Enhanced Fibrinolysis
Mairuhu A	-	Plasma Levels of PAI-1 and Risk of Death from Dengue: No Association with the 4G/5G Promoter Polymorphism
Majcen-Vivod B	-	Heparin Induced Thrombocytopenia (HIT) with Thrombosis – Case Report
Majewski I	-	Molecular Dissection of Platelet Production Via Random Mutagenesis
Makimbetov E	-	Study of Spontaneous Production of Cytokines in Patients with Depression of Haemopoiesis During High Mountainous Adaptation.
Mäkisalo H	-	Generation of Activated Protein C and Phagocyte Activation Associated with Immmunosuppression Using Anti-Thymocyte Globulin for Kidney Transplantation
Makni S	-	Antiphospholipid Syndrome and Risk of Myocardial Infarction in Young: A Preliminary Study
Makogonenko E	-	Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein
	-	Identification of Regions in Low-Density Lipoprotein Receptor-Related Protein Responsible for Interaction with A2 and A1/A3-C1-C2 Portions of Coagulation Factor VIII
Makogonenko E	-	The A2 Domain of Coagulation Factor VIII Shares Residues Critical for Interaction with Three Members of LDL Receptor Superfamily – LRP, VLDL and Megalin Receptors
Makoto I	-	Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors
Makris M	-	Use of the Dade-Behring Multicalibrator Certified Plasmas for Local Calibration of INR
	-	Evaluation of a New Factor Xa-based Antithrombin assay
Makris PE	-	Linear and Cyclic RGD Peptides Containing Salicylic Acid Derivatives and Their Antiplatelet Activity In Vitro
Makris PE	-	The Possible Protective Role of FXIII Leu34 Allele in Thromboembolic Episodes. Its Coexistence with FVL and PAI-1 (4G/5G) Mutations in Thrombophiliacs
	-	Thrombophilic Mutations: A Comparison between the Microarray Technique and the Solid Phase Oligonucleotide Ligation Assay (SPOLA)
Makris PE	-	Use Of F1+2 and TAT as Markers of Prothrombinase Activity in Hemophiliacs
Makris M	-	Reproducibility of the Endogenous Thrombin Potential by Calibrated Automated Thrombogram Assay
Makris PE	-	HIT-II: Therapeutical Use of Fondaparinux (Our Experience)
	-	Drug induced inhibition of platelet function and immune hemolytic anemia (CASE REPORT)
Makris M	-	Influence of Factor V Leiden and Lupus Anticoagulant on a New Venom-Based Clotting Assay of Protein C
	-	Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect
Makris M	-	Haemoperitoneum Associated with Ovulation in Women with Autosomal Recessive Bleeding Disorders
Makris M	-	rFVIIa (NovoSeven^®) for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients with Inhibitors: A Double-Blind Study of a Single High Dose Versus Standard Multiple Doses of rFVIIa
	-	Preparation of Reference Materials for the Genetic Diagnosis of Thrombophilia
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	Clinical Use of Protamine for the Emergency Reversal of Anticoagulation with Low Molecular Weight Heparin (LMWH)
Makris PE	-	An Inquiry into Death Causes Based on Autopsy Findings
Malý J	-	Acetylsalicylic Acid (ASA) Resistance in Patients with Ischemic Heart Disease (IHD) as Bioindicator of the Treatment Strategy
Malan E	-	An Evaluation of the New ACL TOP Coagulation Autoanalyser
	-	Evaluation of Diamed ID-PaGIA Heparin/PF4 Antibody Test for the Diagnosis Of HITTS
Malan E	-	The Development of a Protocol for Lepirudin Therapy Monitoring
Mälarstig A	-	The TF 5466 a/G SNP is a Novel Regulator of Tissue Factor Expression
	-	Interleukin-18 Predicts Long-term Mortality in Patients with Non-ST Elevation Acute Coronary Syndrome
	-	Elevated Levels of Interleukin-10 and the IL-10 -819 C/T SNP Are Predictors of Poor Prognosis in Patients with Acute Coronary Syndrome
Malato A	-	Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial
Malato A	-	Successful Treatment of Acquired Haemophilia with FEIBA® and Retuximab®
Malato A	-	Thrombophilia in Young Adults with Ischemic Stroke Not Related to Cardiovascular Risk Factors
	-	Objective Assessment of Pulmonary Embolism Can Be Deferred without Risk
	-	Thrombophilia in Women with Unexplained Fetal Loss
Malaviolle V	-	Fibrinogen-Aa Thr 312 Ala and Factor XIII Val 34 Leu Polymorphisms in Idiopathic Venous Thromboembolism
Malcovati M	-	Type II Mutation (Glu117stop) Causes Factor XI Deficiency by Inducing Allele Specific mRNA Degradation
	-	In-vitro Expression and Functional Characterization of Four Mutations Causing Factor XI Deficiency
Male C	-	Diagnosis of Central Venous Line-Related Thrombotic Events in the Upper Venous System in Children: Combination of Venography, Venous Ultrasound, and Echocardiography
	-	No Major Impact of Prothrombotic Conditions on The Risk of Central Venous Line-Related Thrombotic Events in Children
Malhotra J	-	Factor VIII Expression Induces ER Stress Apoptosis In Cultured Cells and in Mice
Malíková I	-	Changes of Coagulation after Single i.v. Bolus 0.75 mg Per kg of Low Molecular Weight Heparin Enoxaparin During PCI – A Pharmacokinetic Study
Malizos K	-	Factor V Leiden and R2 Mutations, Prothrombin G20210A Mutation and Osteonecrosis
Mall G	-	Intravenous Leiomyosarcoma Presenting As Iliac Vein Thrombosis
Malley AO	-	The Impact of Acquired Thrombophilia on Maternal and Fetal Wellbeing in a Low-risk Population
Malý J	-	The Comparison of Thrombophilic Potential of F V Leiden and F II20210A in Heterozygous Form in Individuals from the East Bohemian Region
Malý R	-	Acetylsalicylic Acid (ASA) Resistance in Patients with Ischemic Heart Disease (IHD) as Bioindicator of the Treatment Strategy
Maly R	-	Lupus Anticoagulant and FV Leiden Associated with Clozapine Use and Venous Thromboembolism
Malyszko JS	-	Effects of Long-Term Simvastatin Treatment on Some Hemostatic Parameters in Hyperlipidemic Patients with Ischemic Heart Disease
Malyszko J	-	Effects of Long-Term Simvastatin Treatment on Some Hemostatic Parameters in Hyperlipidemic Patients with Ischemic Heart Disease
Malyszko J	-	Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Stable Angina Pectoris Patients Undergoing Coronary Artery Bypass Grafting (CABG)
Malyszko JS	-	Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Stable Angina Pectoris Patients Undergoing Coronary Artery Bypass Grafting (CABG)
Malyszko J	-	Hepcidin: A Link between Anemia, Inflammation and Liver Function in HD Patients?
Malyszko JS	-	Hepcidin: A Link between Anemia, Inflammation and Liver Function in HD Patients?
Mammen JJ	-	Data From APTT Clot Curves of Automated Photo-Optical Coagulometers Correlates Better with Heterogeneity of Clinical Presentation in Severe Hemophilia A than FVIII: C Levels
	-	Successful Surgical Haemostasis in Patients with von Willebrand Disease with Koate^®DVI
	-	Ristocetin Cofactor (VWF:Rco) Assay – A Comparison of a Rapid Automated Method on ACL10000 Coagulometer and Conventional Aggregometry
Mammo L	-	Prevalence of FVL, Prothrombin G20210A and MTHFR C667T in Saudi Arabia: A preliminary report for the Saudi Thrombosis and Familial Thrombophelia (S-TAFT) Registry
Mamoru H	-	Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors
Manabe I	-	Significance of the Transcription Factor KLF5 in Cardiovascular Remodeling
Manai Z	-	Antiphospholipid Syndrome and Risk of Myocardial Infarction in Young: A Preliminary Study
Manari A	-	Cocoa Beverage Shows Platelet Inhibition Activity, Depressing Platelet Activation Antigens CD61, CD62p and PAC1 and Extending the PFA 100 Closure Time
Manco-Johnson M	-	Leukemia after P32 Radionuclide Synovectomy for Hemophilic Arthropathy
Mancuso ME	-	Pharmacokinetics, Efficacy and Safety of Solvent/Detergent (S/D) Treated Plasma in Patients with Rare Inherited Coagulation Disorders (RICDs)
Mancuso G	-	Protective Effect of Human Plasma-Derived Protein C in Septic Neonatal Mice
Mancuso ME	-	High Success Rate of Immune Tolerance Induction with Recombinant Factor VIII (rFVIII) in High-responders with Intron 22 Inversions (int22inv) in the F8 Gene
	-	Prophylaxis with Factor VIII Protects Children with Hemophilia a from Inhibitor Development
Mancuso G	-	Prophylaxis with Factor VIII Protects Children with Hemophilia a from Inhibitor Development
Mandalà M	-	The G1691A Factor V and G20210A Prothrombin Gene Mutations Are Not Associated to an Increased Risk of Venous Thromboembolism (VTE) in Patients with Gastrointestinal (GI) Carcinoma
Mandel M	-	Evaluation of Pro-angiogenic and Pro-Coagulant Activity of Irradiated, Non Irradiated and Filtered Stored Blood Used in Transfusion Practice
Manduteanu I	-	VCAM-1 as Target for Immunoliposome-Mediated Drug Delivery to Activated Endothelial Cells
Manea M	-	Expression of ADAMTS13 in Normal Renal Cortex and in Thrombotic Thrombocytopenic Purpura
Maneyro A	-	Correlation Between Compresive Ultrasonography and D Dimer Levels in Patients with Deep Venous Thrombosis
Manfredi E	-	Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study
	-	Abdominal Obesity and the Risk of Recurrent Deep Vein Thrombosis
Manganiello V	-	The Importance of PDE3A in the Regulation of Platelet Aggregation
Mangin P	-	Specific Role of the GPVI/FcRg Complex in Promoting Thrombus Formation Following Superficial But Not Deep Arterial Injury
Mangin P	-	Distinct Roles for the Type I PI 3-Kinases, p110b and p110g, in ADP-Stimulated Platelet Activation
Mani H	-	Use of Native or Platelet Count Adjusted Platelet-Rich Plasma for Platelet Aggregation Measurements
Mani H	-	Monitoring of Aspirin and Clopidogrel Response in Patients with Arterial Occlusive Disease with Different Platelet Function Methods
Mani H	-	Genetic variants in COX 1-, GP Ia/IIb- and FXIIIa-subunits: Effects on Response to Aspirin in Patients with Peripheral Arterial Occlusive Disease
Mani H	-	Thrombophilia in Inherited Antithrombin Deficiency
	-	Development and Clinical Evaluation of Two Chromogenic Substrate Methods For Monitoring Fondaparinux Sodium
Manigrasso MR	-	Insulin Resistance and Platelet Activation in Obese Women
	-	Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria
Manithody C	-	The Functional Significance of the Autolysis Loop of Protein C and Activated Protein C
Maniu H	-	Cardiomyogenic Differentiation Induced by in vitro Manipulation of Adult Stem Cells
Mann KG	-	Activity and Content of Factor VIII in Various Factor VIII Products
	-	What All That Thrombin Is for
	-	The Influence of Bivalirudin on Tissue Factor-Initiated Thrombin Generation
Mann K	-	Anticoagulant Effects of Statins and Angiotensin-Converting Enzyme Inhibitors in Stable Patients with Coronary Artery Disease: Results of a Randomized Double Blind Study
Mann KG	-	Quantitation of FVIII Antigen in Human Plasma
	-	Molecular Models of the Prothrombinase Complex
	-	Synergistic Antagonists for Hemophilia Treatment
Mann K	-	Simvastatin Given for 3 Days Can Inhibit Thrombin Generation and Activation of Factor V, and Enhance Factor Va Inactivation in Hypercholesterolemic Patients
Mannhalter C	-	Favourable Pregnancy Outcome in Women with a History of Venous Thromboembolism and Prophylactic Low Molecular Weight Heparin (LMWH)
	-	C-Reactive Protein 3'UTR (+1444) C>T Polymorphism in Patients with Spontaneous Venous Thromboembolism
	-	No Major Impact of Prothrombotic Conditions on The Risk of Central Venous Line-Related Thrombotic Events in Children
Mannini L	-	Platelet Function Predicts Myocardial Damage in Patients with Acute Coronary Syndromes Treated with Multiple Antiplatelet Agents
	-	Warfarin Therapy in AF Patients: Females Are Still at Risk
	-	MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study
	-	eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms
	-	Ischemic Complications in Nonvalvular Atrial Fibrillation Patients Despite Warfarin Therapy
Manno C	-	May-Thurner Syndrome (Ileofemoral Vein Thrombosis) in Adolescents with Additional Thrombophilic Risk Factors
	-	Cystic Fibrosis is a Significant Risk Factor for Recurrent Venous Thrombosis at a Pediatric Tertiary Care Hospital
Manns JM	-	Extremely High Levels of Thrombospondin-1 in a Patient Afflicted with Rheumatoid Arthritis are Correlated with Activation of the Coagulation and Fibrinolytic Systems
	-	A Synthetic Peptide Derived From Thrombospondin-1 (TSP1) Type 3 Repeats Modulates Angiogenesis and the Disease Course in an Animal Model of Rheumatoid Arthritis (RA) by Down-Regulating Connective Tissue Growth Factor (CTGF) Expression
Mannucci PM	-	Evidence of Normal Thrombin Generation in Cirrhosis Despite Abnormal Conventional Coagulation Tests
	-	Prophylaxis with Factor VIII Protects Children with Hemophilia a from Inhibitor Development
	-	The Cost of Care of Hemophilic Patients without Inhibitors: The Coche Study
	-	Relationship between CYP2C9 and VKORC1 Polymorphisms and Anticoagulant Dose Requirement
	-	Low Protein Z Levels and Venous Thrombosis
	-	Perturbation of pKa Values of Catalytic Residues in the NATURAL Thrombin: Mutant with Deletion of Lys9 in The A-Chain
	-	Risk Factors for Thrombophilia in Extra-Hepatic Portal Vein Obstruction
	-	Ristocetin Accelerates Von Willebrand Factor (VWF) Hydrolysis Rate and Ameliorates Collagen Binding Assay (CBA) Sensitivity
	-	High Success Rate of Immune Tolerance Induction with Recombinant Factor VIII (rFVIII) in High-responders with Intron 22 Inversions (int22inv) in the F8 Gene
	-	Long Term Prophylaxis of Bleeding Episodes in Patients with von Willebrand Disease: Efficacy and Safety of Factor VIII/von Willebrand Factor Concentrates
	-	Differences between Patients’, Physicians’ and Pharmacists’ Preferences for Treatment Products in Hemophilia. A Discrete Choice Experiment
	-	Prospective Study on Acute Thrombotic Microangiopathy (TMA) after Bone Marrow Transplantation (BMT): Role of ADAMTS13, VWF:Ag and High Molecular Weight von Willebrand Factor (HMW : VWF)
	-	Role of Chloride Ions in the Modulation of the Interaction between von Willebrand Factor and Adamts-13
	-	Antithrombotic Porphylaxis During Pregnancy in Women with Previous Venous Thromboembolism
	-	Quality of Life in Hemophilic Patients without Inhibitors: The Coche Study
	-	Pharmacokinetics, Efficacy and Safety of Solvent/Detergent (S/D) Treated Plasma in Patients with Rare Inherited Coagulation Disorders (RICDs)
	-	In vitro Expression Studies and Immunofluorescence Microscopy Analysis of Two Naturally Occurring Mutations on Factor X (FX) Gene (G94R And D95E)
	-	Quality of Life is Associated to Orthopedic Status in Hemophilic Patients with Inhibitors
Manolopoulos P	-	Derivatives of Coenzyme A Inhibit Platelet Aggregation via Effects at P2Y₁ and P2Y₁₂ Receptors
Manolopoulos P	-	Involvement of P2Y₁and P2Y₁₂Receptors in Platelet Responses to Adenosine Diphosphate and Thrombin Receptor Activating Peptide
Manolopoulos P	-	Platelet Aggregation, Microparticle Formation and Platelet-Leukocyte Conjugate Formation Induced by Combinations of 5-HT and Epinephrine Are Inhibited by Sarpogrelate and BP-984
Manoni M	-	Semi-Synthetic Sulfaminoheparosans Induce Tissue Factor Pathway Inhibitor Release by Human Umbelical Vein Endothelial Cells (HUVEC)
	-	Development of Non-Anticoagulant Derivatives of K5-Derived Sulfaminoheparosans and Investigation of Their Non-Anticoagulant Effects
	-	Sulfaminoheparosan Mediated Inhibition of Tissue Factor Induced Generation of Proteases as Studied by Protein Chip Array Analysis
	-	Protamine Sulfate Is Capable of Neutralizing Bacterial Core Polysaccharide Derived Sulfaminoheparosans
	-	Antithrombotic Effects of Bacterial K5-Derived Sulfaminoheparosans in a Jugular Vein Crush Model of Thrombosis in Rats
Mansour A	-	Elevated Serum Nerve Growth Factor (NGF) Levels in Patients with Acute Leukemia and Lymphoma Especially with CNS Involvement
Mantoni M	-	Congenital Aplasia of the Inferior Vena Cava Is a Major Risk Factor for Iliofemoral Deep Venous Thrombosis. A Prospective One-centre Study of 50 Cases
Mantovani L	-	Quality of Life in Patients with Haemophilia – An European Comparison Study (ESCHQoL)
	-	Conjoint Analysis to Elicit Preferences on Anticoagulant Treatment in Patients Receiving Vitamin K Antagonists (VKA)
Mantovani LG	-	The Cost of Care of Hemophilic Patients without Inhibitors: The Coche Study
Mantovani A	-	Pentraxin 3 in Patients with Pulmonary Embolism
Mantovani LG	-	Quality of Life is Associated to Orthopedic Status in Hemophilic Patients with Inhibitors
	-	Quality of Life in Hemophilic Patients without Inhibitors: The Coche Study
Mantovani L	-	Quality of Life (QoL) in Patients Receiving Vitamin K Antagonists (VKA): A Study Using EQ-5D Questionnaire
Mantovani LG	-	Differences between Patients’, Physicians’ and Pharmacists’ Preferences for Treatment Products in Hemophilia. A Discrete Choice Experiment
Manzato F	-	Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism
Mao G	-	Transcriptional Regulation of PLC-b2 Gene in Human Megakaryocytic Cell Line
Mapatuna K	-	Platelet Activation in Whole Blood, Red Cell Concentrates and Whole Blood Derived Platelet Concentrates
Mara SM	-	Inhibitor Development in Previously Untreated or Minimally Treated Patients with Hemophilia a Treated with a Plasma-derived Solvent-detergent Factor VIII Concentrate
Mara[ccaron]i[ccaron] I	-	Heparin Induced Thrombocytopenia (HIT) with Thrombosis – Case Report
Maratta A	-	Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy
Marcato S	-	FV Leiden Mitigates Bleeding Tendency in Recessive Type 1 von Willebrand Disease
Marchese P	-	Role of the Platelet P2Y1 Receptor in Thrombus Formation Under Flow Conditions
Marchetti G	-	Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions
	-	Intragenic and Extragenic Components Modulating Coagulation Factor VIII Levels and the Risk of Venous Thrombosis
	-	Fluorescence-Based Study of Nonsense Mutation Suppression in Coagulation Factor VII Deficiency
Marchetti M	-	Parallel Changes in Procoagulant Activity and Proangiogenic Capacity of Breast Cancer and Leukaemia Cells Exposed to All Trans Retinoic Acid (ATRA)
	-	ADAMTS-13 Activity Profile in Thrombotic Thrombocytopenic Purpura (TTP) Patients Prospectively Followed At A Single Centre
Marchi R	-	Delayed FPA Release from Homophenotypic Aa 16 H (Fibrinogen Kingsport): Major b Fibrin Epitope Role in Clotting Times and Branching
Marchioli R	-	Prevalence and Clinical Significance of IgG and IgM Anti-Protein S (aPS) and Anti-Annexin V (aAV): Retrospective and Prospective Analysis of the WAPS Study
	-	Clinical Significance o IgG and IgM Anti-Phospholipid (aPL), Anti-Beta2-Glycoprotein I (aBeta2GPI), and Anti-Prothrombin (aPT) Antibodies: Retrospective and Prospective Analysis of the WAPS Study
Marchiori A	-	Increased Risk of Recurrent Venous Thromboembolism in Patients with Deep-Vein Thrombosis Who Are Carriers of the Factor V Leiden or Prothrombin Gene Mutation. A Meta-Analysis
Marcinkiewicz M	-	Macromolecular Substrate-Binding Exosites on Both the Heavy and the Light Chain of Factor XIa Mediate the Formation of the Michaelis Complex Required for Factor IX-Activation
Marco P	-	The EACH Registry: A Prospective European Registry of Acquired Haemophilia (AH)
Marcucci R	-	High Risk of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism
	-	Platelet Function Predicts Myocardial Damage in Patients with Acute Coronary Syndromes Treated with Multiple Antiplatelet Agents
	-	Thrombophilia Is Frequent in Superficial Vein Thrombosis and Is Associated with Recurrence: A Retrospective Study
	-	Asymmetric Dimethyl Arginine (ADMA), Homocysteine and Semicarbazide-Sensitive Amine Oxidase Activity (SSAO): New Markers of Oxidative Stress in Acute Coronary Syndromes
	-	Protein Z Plasma Levels in Different Phases of Activity of Coronary Atherosclerosis
Marcucci R	-	Thrombophilia in Patients with Spinal Cord Injury
Marcucci R	-	More Carotid Atherosclerosis in HCV Positive Italian Patients?
	-	Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease
	-	The Contemporary Presence of Elevated Levels of Factor VIII and PAI-1 Is a Risk Factor for Recurrent Thromboembolism. A Retrospective Case–Control Study
	-	Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activable Fibrinolysis Inhibitor (TAFI) in Juvenile Deep Vein Thrombosis
	-	Inflammatory Markers are Associated with the Abdominal Aortic Diameter
Marder VJ	-	Magnesium Sulfate in Doses Up to 8-Fold Greater than Physiologic Concentration does Not Affect TPA-Mediated Clot Lysis: An in vitro Study
	-	Supplemental Alpha-2-Antiplasmin Prevents Plasmin-Induced Hemorrhage
Marès P	-	The Factor V Leiden and Prothrombin 20210G>A Mutations as Risk Factors for Miscarriage during the First Pregnancy: The Matched Case–Control ‘Big NOHA First’ Study
Marfisi RM	-	Prevalence and Clinical Significance of IgG and IgM Anti-Protein S (aPS) and Anti-Annexin V (aAV): Retrospective and Prospective Analysis of the WAPS Study
	-	Clinical Significance o IgG and IgM Anti-Phospholipid (aPL), Anti-Beta2-Glycoprotein I (aBeta2GPI), and Anti-Prothrombin (aPT) Antibodies: Retrospective and Prospective Analysis of the WAPS Study
Margaglione M	-	The COX-2 G/C-765 Polymorphism Modulates the Occurrence of Cerebrovascular Ischemia
	-	Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma
	-	Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma
	-	Higher Warfarin Requirement in Anticoagulated Antiphospholipid Syndrome Patients to Acquire the Target INR
Margareta B	-	Recombinant Tissue Factor (rTF) and Tissue-Plasminogen Activator (t-PA) Used in a Global Assay to Determine Overall Haemostasis Potential (OHP) in Plasma
Margaritis P	-	Hemostatic Effects of Long-Term Expression of Activated Murine FVII in Normal and Hemophilic Mice
Margheri M	-	Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease
	-	Protein Z Plasma Levels in Different Phases of Activity of Coronary Atherosclerosis
Margue C	-	A New Functional Role of the Fibrinogen RGD Motif as the Molecular Switch that Selectively Triggers Integrin aIIbb3-Dependent Cell Spreading, but not Cell Attachment
	-	A Gain of Function Mutation in aIIbb3 Results in a Glanzmann Thrombasthenia Phenotype
Mari D	-	TAFI 325/Ile Genotype in Old Population of Northern Italy
Mari D	-	Impaired Bradykinin Response to Ischemia and Exercise in Patients with Mild Congestive Heart Failure During Angiotensin-Converting Enzyme Treatment. Relationships with Endothelial Function, Coagulation and Inflammation
	-	Homocysteine Plasma Levels and MTHFR Genotype in Patients with Retinal Vein Occlusion
Maria DA	-	Amblyomma Cajennense Tick: The Transcriptome, Expression and Biochemical Characterization of a Factor Xa Recombinant Inhibitor
Mariak Z	-	Transcranial Color Doppler Sonography in the Diagnosis of Middle Cerebral Artery Spasm
Mariak Z	-	Transcranial Color Doppler Sonography in the Diagnosis of Middle Cerebral Artery Spasm
Mariani G	-	Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial
	-	Fluorescence-Based Study of Nonsense Mutation Suppression in Coagulation Factor VII Deficiency
	-	Objective Assessment of Pulmonary Embolism Can Be Deferred without Risk
	-	Bleeding Determinants in Congenital FVII Deficiency
Mariani G	-	The Management of Congenital FVII Deficiency
Marietta M	-	Inherited Bleeding Disorders: The Emilia-Romagna Region Register, 2004 Update
Marín F	-	Factor XIII Val34Leu Polymorphism Showed an Adverse Pharmacogenetic Effect on the Thrombolytic Therapy for Acute Myocardial Infarction
	-	Synergism between Functional Hemostatic Polymorphisms and Risk of Premature Myocardial Infarction
	-	Synergistic Association between Hypercholesterolemia and C46T Factor XII Polymorphism in the Development of Premature Myocardial Infarction
	-	Pharmacogenetic Effect of Factor VII -323 Del/Ins Polymorphism on Diurnal Variation of Factor VII Coagulant Activity and INR in Steady Anticoagulated Patients with Atrial Fibrillation
Marinee C	-	Neonatal Gene Therapy with Lentiviral Vector in Murine Hemophilia a Results in Successful Immune Tolerance Induction to Canine Factor VIII
Maritsch F	-	A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
Markakis K	-	The Use Of ROTEM for the Evaluation of Effectiveness of Recombinant FVIIa Administration in Patients with Uncontrollable Bleeding
Markland FS	-	Contortrostatin: A Potent Inhibitor of Cancer Growth and Angiogenesis
Marmur J	-	Phosphorylation of the Extracellular Domain of the F11R/JAM-1 and Its Role in Platelet Aggregation
Marosi C	-	High Incidence of Symptomatic Venous Thromboembolism in Patients with Glioblastoma
Marpeau L	-	Protein Z Polymorphisms, Protein Z Plasma Concentration and Severe Pre Eclampsia
Marques HO	-	Hemostatic Changes in Patients with Malaria
Marreira L	-	Hemostatic Changes in Patients with Malaria
Marrero C	-	Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution
Marsden K	-	Towards Harmonisation of D-dimer Assays
	-	How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa assay? The Laboratory Perspective
Marseglia C	-	Both Haploinsufficiency and Dominant Negative Effect Are Responsible for Hematological Abnormalities of Patients with -Related Disease
Marsh JJ	-	Abnormal Kinetics of Fibrinolysis in Patients with Chronic Thromboembolic Pulmonary Hypertension
Marshall PJ	-	Robustness Testing of OPTIVATE^® Intermediate Purification Stages
Marshall NJ	-	In Patients with the Biphasic Waveform, Lipoprotein Complexation Does Not Retard C-Reactive Protein Induced Complement Activation
Martelli M	-	Inhibition of the Renin-Angiotensin System Modulates the Procoagulant/Fibrinolytic Potential of Human Breast Carcinoma Cells
Martin J	-	Macrophage Gene Expression Appears to Differ between AGE and OxLDL Stimulation
Martin JS	-	Vitamin K Status in Mothers and Their Newborn Babies: Role of Dietary Phylloquinone Intake
Martin JF	-	Injury-Inducible Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21^WAF1/Cip1 Transcription and Perturbing Cyclin D1-Cdk4-p21^WAF1/Cip1 Assembly
Martin JWI	-	Metabolic Arrest Suppresses Platelet Binding to and Phagocytosis by Macrophages
Martin K	-	Combination of Loss of Function of Recombinant R1334A-VWF and Gain of Function of R1336A-VWF Results in a Loss of Function of RKR1334-1335-1336A-VWF
Martin C	-	Different Patterns of Release of the Soluble Form of the Endothelial Protein C Receptor in Critically Ill Patients
Martin J	-	Gene Expression Comparison Between Monocytes in Culture and Atherosclerotic Laser Microdissected Resident Macrophages
Martineau J	-	Optimizing Thromboembolic and Stroke Prevention: Interim Analysis of a Randomized Controlled Trial of Pharmacist-Managed Oral Anticoagulotherapy (PHARMA Trial)
Martinelli I	-	Molecular Characterization in an Italian Patient with Plasminogen Deficiency And Ligneous Conjunctivitis
Martinelli I	-	Antithrombotic Porphylaxis During Pregnancy in Women with Previous Venous Thromboembolism
Martinelli N	-	Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project
Martinelli I	-	Risk Factors for Thrombophilia in Extra-Hepatic Portal Vein Obstruction
Martinelli I	-	Low Protein Z Levels and Venous Thrombosis
Martinelli N	-	Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism
Martinelli T	-	Application of Filtration Technologies for Prion Removal from Plasma Product Intermediates
Martinez C	-	Deleterious Effect of the Common FXIII Val34Leu Polymorphism in Patients with Ischemic Stroke Treated with Fibrinolytic Therapy
Martinez MB	-	Plasma Proteomics in Human Endotoxemia: A Novel Approach Using MALDI-TOF Profiling and iTRAQ Labeling Reveals Oxidation Of Plasma Proteins and Other Significant Changes
Martinez M	-	Favorable Outcome in the Pregnancy behind Treatment with Heparin in Women with Mutation of Methylenetetrahydrofolate Reductase (MTHFR) Gene and Fetal Loss Previous
Martinez AM	-	The Behavior of Anticardiolipin Antibodies Levels in Patients with Venous Thromboembolism
Martínez C	-	Conformational and Functional Changes in Antithrombin by Oxidation
Martinez MB	-	Proteomic Analysis of Platelets and Platelet-Derived Microparticles by iTRAQ Labeling and Mass Spectrometry
Martinez C	-	Platelet Dysfunction Associated with Reduced Gai Expression in a family with Inherited Bleeding Disorder
Martinez I	-	Screening of Phage Displayed Random Peptide Libraries Reveals Conformational Epitopes of Inhibitors in a Haemophilia B Patient
Martínez J	-	The First Homozygous Family for Factor II G20210A Mutation in Latin America
Martínez C	-	Inherited Mucocutaneous Bleeding: Clinical Assessment, Relative Frequency of Diseases and High Prevalence of Bleeders with Normal Laboratory Tests: Prospective Study of 280 Patients and 299 Non Bleeder Controls
	-	Interaction of Selected Septin Proteins with Platelet Microtubules: Role in the Regulation of Platelet Exocytosis
Martinez P	-	Prothrombotic Risk Factors of Fabry Patients in Argentina
Martinez C	-	Ciclooxygenase-1 C50T Polymorphism Modulates the Thromboxane A₂ Level and might Affect the Efficacy of Aspirin
	-	Antagonism of TxA₂ Receptor Plays a Major Role in the Inhibitory Effect of Flavonoids in Platelet Function
Martinez Saguer I	-	Pharmacokinetics of C1 Esterase Inhibitor, Human (Pasteurized) in Subjects with Hereditary Angioedema
Martinez Saguer I	-	Treatment of Acute Angioedema Attack with Icatibant in a Patient with Hereditary Angioedema due to C1-Inhibitor-Deficiency
Martínez-Bugallo A	-	Oral Anticoagulant Treatment (OAT) with Portable PT Monitor in Primary Health Care Centres with Immediate Dose Adjustment by the Hospital OAT Unit
Martinez-Marchan E	-	Effect of F7 Gene Promoter Polymorphisms on Factor VII Antigenic Levels
Martinez-Saguer I	-	Cranial Epidural Bleeding in a Child with Congenital Afibrinogenaemia, Management and Long-Term-Prophylaxis with a Fibrinogen Concentrate
	-	Individual Replacement Therapy (IRT) with C1-Inhibitor Concentrate in Patients with Severe Hereditary Angioedema Increases Significantly Quality of Life Parameters Compared to Danazol Prophylaxis
Martínez-Sanchez E	-	The ABO Blood Group Genotype and Factor VIII Levels as Independent Risk Factors for Venous Thromboembolism
Martini F	-	Hypercoagulability May Predict Embryo Implantation after Assisted Reproductive Procedures
Martini WZ	-	Effects of Acidosis and Hypothermia on Whole Blood Clotting Function in Swine
	-	Differential Effects of Acidosis and Hypothermia on Clot Development in Swine
Martini A	-	Warfarin Therapy in AF Patients: Females Are Still at Risk
Martin-McNulty B	-	Tissue Factor-Neutralizing Antibody Fused to Thrombomodulin (Ab(TF)-TM) Has Amplified Anticoagulant Efficacy in a Rat Model of Thromboembolism
Martinowitz U	-	Autologous Bone and Marrow Grafted within a Clot of Platelet Rich Plasma Construct Normal Viable Bone
	-	Mechanisms of Thrombin Generation Induced by High Concentrations of Recombinant Factor VIIa
Martinowitz U	-	Concomitant Infusion of Low Doses of rFVIIa and FEIBA in Severe Hemophilia A Patients with an Inhibitor to Factor VIII Who Are Refractory to rFVIIa or FEIBA Has an Excellent Hemostatic Effect and Synergistically Enhances Thrombin Generation
Martins E	-	Effects of Leptospiral Proteins on Human Endothelial Cells
Martins Filho OA	-	Monocytes and Plasma Tissue Factor Levels in Normal Individuals and Patients with Lower-Limbs Deep Venous Thrombosis: Potential Diagnostic Tools?
Martinuzzo M	-	Comparison Among the New Immunoassays with Monoclonal Antibody Calibration and Home-Made Methods for Testing the Antiphospholipid Antibody (APA) Family
	-	Impact of Different Thromboplastins on the International Normalized Ratio and MELD Score in Patients with Cirrhosis Listed for Liver Transplantation
	-	The Combination of LA with Antibodies to B2-Glycoprotein I (anti-B2GPI) and Prothrombin (anti-PT) Predicts a Higher Risk of Thrombosis
Martinuzzo M	-	A Lower Calcium Concentration Prolongs More Frequently Dilute Prothrombin Time (dPT) of Patients with Lupus Anticoagulant (LA) and Anti-B2GPI Antibodies (aB2GPI)
Martorell D	-	DG-Chrom AT: A New Commercial Antithrombin (AT) Assay (Anti-FXa)
Martyres A	-	Interaction of Plasminogen and Angiostatin with Heat Shock Proteins
Marutsuka K	-	Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo
Maruyama I	-	Endocannabinoid Anandamide Induces High Mobility Group Box 1 (HMGB1) Protein Release in Monocytes and Macrophages
	-	High Mobility Group Box Protein Is Increased in the Plasma and May Have a Role in Development of Organ Failure in DIC
Maruyama I	-	Thrombomodulin Binds Lethal Cytokine HMGB1 and Neutralizes Its Pro-inflammatory Activity: Novel Cytoprotective Action of Thrombomodulin
Marx PF	-	Role of Isoleucine Residues 182 and 183 in Thrombin-Activatable Fibrinolysis Inhibitor
Marx P	-	Elucidation of the Binding Regions of TAFI Neutralising Antibodies Reveals Different Molecular Targets for Thrombin vs Plasmin Mediated TAFI Activation
Marx M	-	No Major Impact of Prothrombotic Conditions on The Risk of Central Venous Line-Related Thrombotic Events in Children
März W	-	Lipoprotein Pattern in Patients with Retinal Artery Occlusion or Retinal Vein Occlusion
Marzec U	-	Prolonged Anticoagulation and Sustained Therapeutic Endogenous Activated Protein C (APC) Levels during Protein C Activation in Primates by a Thrombin Variant
Mar-Zeev P	-	A New Approach for Pre Analytical Screening of Hospitalized Patients Receiving Anticoagulant Therapy
Marziali S	-	Prevalence and Clinical Significance of IgG and IgM Anti-Protein S (aPS) and Anti-Annexin V (aAV): Retrospective and Prospective Analysis of the WAPS Study
	-	Clinical Significance o IgG and IgM Anti-Phospholipid (aPL), Anti-Beta2-Glycoprotein I (aBeta2GPI), and Anti-Prothrombin (aPT) Antibodies: Retrospective and Prospective Analysis of the WAPS Study
Marzilli L	-	Comparative Structural Analysis of Recombinant Factor VIII (rFVIII): Defining Full-Length FVIII
Marzotko S	-	Elevated Prothrombin Fragment F1 + 2 Levels during Pregnancy in Women with Previous Venous Thromboembolism
Masahiro I	-	Decreased Contribution of ADP and Thromboxane A₂ to Aggregation Induced by Collagen in Platelets from Chediak-Higashi Syndrome Affected Cattle
Masaki A	-	Purification and Characterization of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells
Masaru S	-	Neonatal Gene Therapy with Lentiviral Vector in Murine Hemophilia a Results in Successful Immune Tolerance Induction to Canine Factor VIII
Masatoshi T	-	Biological Properties of a Specific Ga_q/11 Inhibitor, YM-254890, on Platelet Functions and Thrombus Formation under High-shear Stress
Masci P	-	Characterisation of the Anticoagulant Properties of a Phospholipase A₂ from the Venom of the Australian King Brown Snake (Pseudechis australis)
Masci PP	-	Slow Lysis of Porcine Blood Clots Is Caused by Resistance of Plasminogen to Activation
Masenko V	-	Matrix Metalloproteinases and Markers of Thrombin Generation in Patients with Restenosis after Percutaneous Coronary Interventions
Masereeuw R	-	DDAVP Treatment Is Not Recommended in Patients with von Willebrand Disease Type 2N
	-	Low Amounts Of rVIIa Are Sufficient to Trigger Initiation of Thrombin Generation in Factor VII Deficient Patients
Mash'hadi Rahimi B	-	Dental Procedure Using Recombinant Activated Factor VII (Novo Seven) in 22 Patients with Platelet Function Disorder in Iran
Masikat MR	-	Tissue Factor Targeted Thrombomodulin (Ab(TF)-TM) – a Novel Tissue Factor Neutralizing Antibody Fused to Thrombomodulin (TM)
Masina IV	-	Inflammation, Disease Activity Indices and Hemostatic Markers in Patients with Systemic Lupus Erythematosus
Maslac A	-	Miconazole Oral Gel and Nystatin Solution Potentiates Warfarin Anticoagulant Activity
Masopust J	-	Lupus Anticoagulant and FV Leiden Associated with Clozapine Use and Venous Thromboembolism
Masotti L	-	Prognostic Role of Inflammatory Markers in Elderly Patients with Acute Ischemic Stroke
	-	Acute Phase of Inflammation and Mortality in Elderly Patients with Pulmonary Embolism
Masotti L	-	Epidemiology of Pulmonary Embolism in Elderly Patients Admitted in an Italian Teaching Hospital: Preliminary Data of a Ten years Retrospective Analysis
Masova L	-	Functional Characterization of the FXIII Cross Linking Sites in the Fibrinogen g-Chain
Massardo L	-	Circulating Platelet-Derived Microparticles in Systemic Lupus Erythematosus: Association with Increased Thrombin Generation and Procoagulant State
Massaro M	-	MAP-Kinase/NF-kB-Dependent Endothelial Activation and Inhibition of PI3-kinase/Nitric Oxide Are Both Involved in Pro-Atherogenic Effects of Insulin – A Link to the Pathogenesis of Accelerated Atherosclerosis in Diabetes
	-	Anti-Angiogenic Action of Peroxisome Proliferator-Activated Receptor(PPAR)g Ligands Through Cox-2-Mediated MMP-9 Expression and Release
	-	Homocysteine (Hcy) Stimulates Endothelial Vascular Cell Adhesion Molecule(VCAM)-1 Via Nuclear Factor(NF)-kB Activation Induced by an Increase of Reactive Oxygen Species (ROS): Protective Role by Natural Antioxidants
Massaro A	-	Sticky Platelet Syndrome Is a Cause of Cerebral Venous Thrombosis
Massberg S	-	Reduced Platelet Adhesion, Attenuated Atherosclerosis and Increased Resistance to Focal Cerebral Ischemia in Mice Lacking GPIIb Integrin
	-	Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood
	-	Glykoprotein VI Mediates Platelet Adhesion to Vulnerable Human Atherosclerotic Plaque
	-	In vivo Relevance of Platelets and the Fibrinogen Receptor GPIIb-IIIa for Experimental Melanoma Metastasis
Massé JM	-	Lentivirus Destruction and DC-SIGN Expression by Platelets and Megakaryocytes
	-	HZF as a Candidate Gene for Gray Platelet Syndrome (GPS)
Massicotte P	-	Antiphospholipid Antibody Syndrome (APS) Experience in the Hospital for Sick Children
Massicotte M	-	Incorporation of a Comprehensive Pediatric Thrombosis Program as Part of the Multidisciplinary Care Team for Children with Congenital Heart Disease: A Prospective Cohort Study
Massicotte P	-	KIDCLOT (Kids Informed Decrease Complications: Learning On Thrombosis) ©
	-	No Difference in Incidences of Thrombosis between Heparin Bonded Catheters and Non Heparin Bonded Catheters in Infants in the Critical Care Unit Following Surgery for Congenital Heart Disease: A Randomised Controlled Triple Blind Study
Mast A	-	Thrombophilia-Associated Fetal Loss: Epistasis of Fetal and Maternal Factors
Maszak G	-	Platelet and Inflammatory Alterations Associated with Late Restenosis in Patients Undergoing Angioplasty and Brachytherapy
Matchar D	-	Utility and Multi-site Acceptance of Patient Self-Reporting of INR Self-Test Results to a Central Database Utilizing a Computerized Interactive Voice Response System in the THINRS Study
Mateo J	-	The ABO Blood Group Genotype and Factor VIII Levels as Independent Risk Factors for Venous Thromboembolism
Matetzky S	-	High Rate of Unresponsiveness to Clopidogrel in Patients with Acute Coronary Syndrome (ACS) As Determined by the Impact-R [Cone And Plate(let) Analyzer]
	-	Low rate of Responsiveness to Aspirin in Acute Brain Ischemia: Association with Stroke Severity and Clinical Outcome
Matetzky S	-	Statins Confer a Direct Anti-Platelet Effect in Patients with Acute Myocardial Infarction Treated with Aspirin and Clopidrogel: Ex-vivo and in-vitro Study Results
Matevosyan K	-	Lack of Correlation between OD Value of Elisa and Clinical Thrombosis in Patients with Heparin Induced Thrombocytopenia (HIT)
Mather T	-	The Crystal Structure of Unliganded Thrombin Identifies Regions Involved in Allosteric Regulation by Thrombomodulin
Mather H	-	Measurements of Soluble Thrombomodulin Activity and Antigen: Factors Contributing to Variance and Potential for Identification of Protein Variants
Mather H	-	Cardiovascular Risk Factors Contributing to Endogenous Thrombin Potential (ETP) in Type 2 Diabetes
Mathew P	-	Successful Use of FEIBA to Control Postoperative Bleeding after Use of rFVIIa
Mathew P	-	Cost-Effectiveness of Different Treatment Regimens Consisting of NovoSeven^® Versus FEIBA VH for the Home Treatment of Minor-to-Moderate Bleeds in Hemophilia Patients With Inhibitors in the United States: A Cost-of-Bleed Model
	-	Use of the Platelet Function Analyzer (PFA-100) in Screening for Platelet Function Defects
Mathews V	-	Successful Surgical Haemostasis in Patients with von Willebrand Disease with Koate^®DVI
	-	Molecular Characterization of Haemophilia B: 17 Novel Mutations in Patients of Indian Origin
	-	Data From APTT Clot Curves of Automated Photo-Optical Coagulometers Correlates Better with Heterogeneity of Clinical Presentation in Severe Hemophilia A than FVIII: C Levels
Mathiesen EB	-	Increased Coagulation Activation in Persons with Echogenic Carotid Plaques
Mathieux V	-	Risk of Venous Thromboembolism (VTE) Related to first Pregnancy in At-Deficient Women. One-Center Study of 43 Pregnant Women without Prophylaxis
	-	Fibrinogen Paris IX: A Case of Symptomatic Hypofibrinogenaemia Associated With Bbeta Y236C and Bbeta IVS7 -1G > C Mutations
Mathijssen NCJ	-	Determination of Platelet Activation Biomarkers Using the Surface Enhanced Laser Desorption/Ionisation Time of Flight (SELDI-TOF) Proteomic Approach
Mathijssen NCJ	-	Administration of Recombinant Activated Factor VII Causes Activation of Integrin a_IIbb₃ on Blood Platelets both in vivo and in vitro, Lowering the Threshold for Activation by Thrombin
	-	Low Amounts Of rVIIa Are Sufficient to Trigger Initiation of Thrombin Generation in Factor VII Deficient Patients
Matic M	-	Homocysteine Levels and MTHFR C677T Genotypes in Patients with Myocardial Infarction under Age 45 years
Matos MF	-	Frequency of Anticardiolipin (aCL) Antibodies in Patients with Lupus Anticoagulant (LA) Detected by Different Methods: An Analysis of 4265 Cases
Matos MF	-	Are Discard Tubes Needed for PT and APTT Assays?
Matsinos G	-	Haemophilic Arthropathy: Contribution of Clinical, X-Ray and MRI Scores in its Diagnosis and Modification of Treatment
Matsubara Y	-	Hepatocytes are the Major Site of ADAMTS-13 Expression in Human Liver
Matsuda M	-	A Novel Molecular Marker of Soluble Fibrin Monomer-Fibrinogen Complex Is Quite Valuable for Diffrential Diagnosis of Septic Pneumonia and Simple Pneumonia
Matsuda J	-	Thrombomodulin Inhibits Tumor Cell Invasion Through Three Different Domains of the Molecule
	-	Circadian Clock Genes are Involved in the Regulation of fibrinolytic Activities in Mice
Matsuda M	-	Degradation of Cross-linked Fibrin by Plasmin Together with Granulocyte-elastase under Certain Clinical Conditions
Matsuda J	-	Circadian Oscillation of Thrombomodulin Gene Expression in Peripheral Tissues
Matsuda M	-	Development of a Latex Agglutination Test for the Measurement of Elastase-Digests of Fibrin in Plasma and Its Application to Clinical Samples
	-	Clinical Importance of Measurement of Soluble Fibrin Monomer-Fibrinogen Complex in Patients with Disseminated Intravascular Coagulation Syndrome and Hypercoagulable State
Matsumoto C	-	Pharmacological Characterization, Antithrombotic and Bleeding Effects of DU-176b, a Novel, Potent and Orally Active Direct Inhibitor of Factor Xa: A Wider Safety Margin of Antithrombotic and Bleeding Effects Compared to Heparin, LMWH and Warfarin
Matsumoto M	-	Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo
Matsumoto C	-	Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents
Matsumoto K	-	Hemostatic Factors and Serum Lipids in Patients with Angina Pectoris Who Underwent Coronary Angiography
Matsumoto T	-	Factor VIII Mimetic Antibody: (2) In Vitro Assessment of Cofactor Activity in Hemophilia A
Matsumoto C	-	Antithrombotic Effects of a Direct Factor Xa Inhibitor, DU-176b, and an Antithrombin Dependent Factor Xa Inhibitor, Fondaparinux, on an Ex vivo Capillary Perfusion Chamber Thrombosis Model in Rats
Matsumoto Y	-	GPVI-Deficient Mice Lack Collagen Responses and are Protected Against Experimentally-Induced Pulmonary Thromboembolism
Matsumoto T	-	Proteinase 3 Expression on Neutrophil Membranes from Patients with Infectious Disease
Matsumoto Y	-	Highly Potent Anti-human GPVI Monoclonal Antibodies Derived from GPVI Knockout Mouse Immunization
Matsumoto LA	-	Homozygous Protein C Deficiency: A Case Report of Neonatal Purpura Fulminans Treated with Activated Protein C Concentrate and High dose of Enoxaparin
Matsumoto M	-	Stellate Cells Produce ADAMTS13 in Human Liver
Matsumoto C	-	Recombinant Factor VIIa Reverses Te Prolonged Bleeding Time Induced B A High Dose of DU-176b, a Novel Direct Factor Xa inhibitor, In Rats
Matsunaga Y	-	Molecular Cloning of Novel Vascular Endothelial Growth Factors from Snake Venoms
Matsuo O	-	Prevention of Postoperative Pulmonary Embolism in the Japanese Academic Medical Center
	-	Intervention of Plasminogen Activator Inhibitor-1 in Nasal Allergy
	-	The Analysis of Fibrinolytic Factors on the Isolated Hepatocyte from Mice in the Process of Liver Regeneration
Matsuo M	-	Anti-Heparin/PF4 Complex Antibodies (HIT Antibodies) in Chronic Uremia Patients Requiring Hemodialysis with Heparin
Matsuo T	-	Anti-Heparin/PF4 Complex Antibodies (HIT Antibodies) in Chronic Uremia Patients Requiring Hemodialysis with Heparin
Matsuo H	-	The Japanese Vein Study: The 2^nd Survey of Deep Vein Thrombosis
Matsushita Y	-	Effective Inhibition of Platelet Aggregation and Release Reaction with Lack of Effect on Shape Change by CS-747 (Prasugrel, LY640315) and Its Active Metabolite
Matsushita T	-	Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice
Matsushita T	-	In vitro Characterization of Two Missense Mutations Associated with Quantitative Protein S Deficiency
Matsuura S	-	Degradation of Cross-linked Fibrin by Plasmin Together with Granulocyte-elastase under Certain Clinical Conditions
Matsuura E	-	Oxidative Modification of Low-density Lipoprotein (LDL) and OxLDL/b2GPI Complexes in Patients with Infectious Endocarditis: Possible Role in Aortic Valve Disease
	-	Circulating oxLDL/b2GPI Complexes, Autoantibodies and Intima-media Thickness in Patients with Systemic Lupus Erythematosus: Possible Role in Autoimmune-mediated Atherosclerosis
Matsuyama S	-	Mechanism of HKa-induced Endothelial Cell Apoptosis
Matsuyama T	-	Stellate Cells Produce ADAMTS13 in Human Liver
Mattarozzi S	-	Shorter aPTT Values Are Associated with Increased Risk of Recurrence of Venous Thromboembolism (VTE) after Oral Anticoagulation (OA) Withdrawal
	-	Extremely Poor Quality of Oral Anticoagulation (OAT) Control during the First Three Months after Unprovoked Venous Thromboembolism (VTE) is a Risk Factor for Long Term Recurrence and is Associated with Higher D-Dimer Levels
Mattei MG	-	Microarray Analysis on Platelet RNA of a Patient with a 22q11 Microdeletion Including the Gpibbeta Gene and Associating Digeorge Syndrome, Moderate Thrombocytopenia and Large Platelets
Matthaei K	-	A Mechanism of Impaired Platelet Response to ADP Stimulation in the CLIC1 Knockout Mice
Mattheisen M	-	Venous Thromboembolism: Involvement of ADAMDEC1 Polymorphisms in Familially High Factor VIII Levels
Matthews P	-	Use of Recombinant Activated Factor VII (Novoseven) as Haemostatic Cover for Surgery in Congenital Factor VII Deficiency
	-	Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases
Matthias T	-	Is the Rate of Clinical Manifestations of the Antiphospholipid Syndrome Associated to Cumulative Findings of Antiphospholipid Antibodies?
	-	Identification of Thrombin Antibodies in Patients with Antiphospholipid Syndrome
Mattiello T	-	DAG Induces Ca²⁺ Influx through NCKX-TRPC Interaction, Independently of PKC Activity
Mattisek C	-	TFPI Degradation by Neutrophil Proteases: Potential Implications in Acute Myocardial Infarction
Mattson JC	-	An Evaluation of Heparin Platelet Factor 4 Antibody Testing
Mattson E	-	The Prevalence of Low von Willebrand Factor Activity and von Willebrand Disease Among Young Women with Bleeding Symptoms
Mattsson C	-	Characterisation If Species Differences in the Platelet Thrombin/ADP Response
Matucci-Cerinic M	-	Systemic Sclerosis: Gene Expression Profiling by Microarray Technology of Endothelial Cells
Matuda J	-	Increased Levels of Hepatocyte Growth Factor in Patients with DIC
Matus V	-	Activated Human Platelets Synthesize Functional Tissue Factor
	-	Plasma proCPU (TAFI) Concentrations and Clot Lysis Time Are Not Different in a Chilean Population of Young Healthy Individuals Subgrouped According to the Naturally Occurring 325 Thr/Ile Polymorphism
	-	Patients with Mucocutaneous Bleeding and Hereditary Disorders of Primary Haemostasis Have Higher Plasma proCPU Levels But a Similar Distribution of the 325 Thr/Ile Polymorphism Compared to Age and Sex Matched Healthy Controls
Matvienko AS	-	Comparative Analysis of the APC Resistance in East Siberian Residences
Matysiak M	-	The Use of Factor VII(rFVIIa) in Surgical Correction of Hypospadiasis in a Child with Haemophilia A Complicated by Presence of Factor VIII Inhibitor
Matý[scaron]kova M	-	Project HemIS (Haemophilia – Information System): Multicentric Information System of Patients with Haemophilia
Matz R	-	Factor VII Activating Protease (FSAP) Inhibits Angiogenesis in vivo
Matz-Westphal R	-	The Junctional Adhesion Molecule-C Promotes Neutrophils Transendothelial Migration in vitro and in vivo
Maugeri N	-	Parnaparin Prevents the Upregulation of Platelet-Leukocyte Interaction in Whole Blood
	-	Polymorphonuclear Leukocytes Express Tissue Factor after Activation with P-Selectin
	-	Leukocyte Activation in Myeloproliferative Disease
	-	Parnaparin Prevents Platelet-PMN Leukocyte Interaction: New Clues to the Antithrombotic Properties of Low Molecular Weight Heparin
Maurel P	-	Secretion of Functional Plasma Coagulation Proteins in Long-term Primary Cultures of Human Hepatocytes
Maurer G	-	Hepatocyte Growth Factor Mediates Induction of PAI-1, Il-6 And Il-8 in Human Adipose Tissue
	-	Cardiac Myocytes and Cardiac Fibroblasts Are Actively Involved in the Recruitment of Monocytes
Maurice P	-	Strong Antithrombotic Effect of the Type III Collagen-Related Octapeptide (KOGEOGPK) in the Mouse
Maurice P	-	TIIICBP: The Platelet Receptor for Type III Collagen is Present into Platelet Membrane Lipid Microdomains (Rafts)
Mauser-Bunschoten EP	-	Childhood Acquired Hepatitis C Infection in Patients with Hemophilia: A Cohort Study
	-	Hemorrhagic risk in Female Carriers of Hemophilia
	-	Influence of Type of Factor VIII Gene Mutation on Inhibitor Development in a Single Centre Cohort of Severe Haemophilia a Patients
	-	Factor VIII Inhibitors in Hemophilia A during Immune Tolerance Induction
Mavri A	-	Polymorphism A36G of the Tumor Necrosis Factor Receptor 1 Gene Is Associated with HDL Cholesterol, TNFR1 and PAI-1 Levels in Obese Women
Maximova M	-	Hemorheology, Hemostasis in Patients with Arterial Hypertension
	-	Hemorheology, Hemostasis and Antiaggregate Activity of Endothelium in Patients with Hypertensive Small Deep Infarcts
	-	The Evaluation of Disfunction of Endothelium in Patients with Atherosclerosis of Carotid System and Reversible Neurological Deficit
	-	Haemorheology and Haemostasis in Ischemic Cerebrovascular Diseases
Maxwell M	-	Distinct Roles for the Type I PI 3-Kinases, p110b and p110g, in ADP-Stimulated Platelet Activation
May JA	-	Platelet Aggregation, Microparticle Formation and Platelet-Leukocyte Conjugate Formation Induced by Combinations of 5-HT and Epinephrine Are Inhibited by Sarpogrelate and BP-984
May JA	-	Dietary Flavanols – Effects on Platelets and Leukocytes
May JA	-	Derivatives of Coenzyme A Inhibit Platelet Aggregation via Effects at P2Y₁ and P2Y₁₂ Receptors
Mayer SA	-	Effects of Recombinant Activated Factor VII on Perilesional Oedema in Patients with Acute Intracerebral Haemorrhage
	-	No Influence of Antiplatelet Therapy on the Outcome of Acute Intracerebral Haemorrhage Treated with Recombinant Activated Factor VII
Mayer S	-	Oral PAI-1 Inhibitor Decreases Thrombosis Without Anticoagulation in a Rat Stenosis Model of Venous Thrombosis
Mayr F	-	The Effects of Supra-Normal Protein C Levels on Markers of Coagulation, Fibrinolysis and Inflammation in a Human Model of Endotoxemia
Mayr FB	-	Anticoagulant and Anti-inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge
Mayr FB	-	Effects of the Pan-Selectin Antagonist Bimosiamose (TBC1269) on LPS Induced Coagulation
Mayr FB	-	Platelet Hyperfunction and Low Response to Aspirin Predict Re-events in Patients With Acute Coronary Syndromes During Long Term Follow Up
Mazar AP	-	Defining the Interaction between Cleaved High Molecular Weight Kininogen (HKa) and Tropomyosin
Mazoyer E	-	The Predictive Value of D-Dimers on the Occurrence of Thromboembolic Events and Death: A Prospective Multicentric Study
	-	Interaction between Paracetamol and Warfarin: A Double-Blind Placebo-Controlled Randomised Study
Mazurier C	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	Bilateral Ankle Prosthesis in a Severe Von Willebrand Disease Patient under Substitutive Wilfactin Treatment
	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
Mazurov AV	-	Ability of Different Glycoprotein IIb-IIIa (aIIb/b3-Integrin) Ligands to Support Platelet Aggregation and Release Reaction Induced by Activating Anti-LIBS Antibody
Mazza P	-	Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers
Mazzola G	-	Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions
	-	Association of High Lipoprotein(a) and Fibrinogen Levels Predicts Coronary Heart Disease and Cerebro-vascular Mortality in an Elderly (>=65 years) Northern Italian Population
Mazzolai L	-	Characterization of Human Endothelial Progenitor Cells Under Various Flow Conditions
	-	Egr-1: A Key Mediator of Oscillatory Shear Stress Induction of Tissue Factor Promoter
Mazzucato M	-	Von Willebrand Factor-Mediated Platelet Adhesion in Flowing Blood is Influenced by Hematocrit
Mazzucato M	-	Integrin a2b1 and Glycoprotein VI Dependent Calcium Signals in Platelets Interacting with Acid-Soluble Type I Collagen Under Flow
Mazzucconi M	-	Central Venous Catheters Related Thrombosis in Hematological Patients
Mazzucconi MG	-	Prophylaxis with Factor VIII Protects Children with Hemophilia a from Inhibitor Development
	-	Different Reactivity of Factor VIII Inhibitor in Congenital and Acquired Haemophilia A
McBane RD	-	Mesenteric Vein Thrombosis: the Etiologic Spectrum of a Unique Thrombotic Disorder
	-	Natural History of Retinal Vein Thrombosis: Incidence of Local and Systemic Recurrence of Venous Thromboembolism
	-	Natural History of Mesenteric Vein Thrombosis: Incidence of Recurrent Venous Thromboembolism and Survival
	-	Post-splenectomy Mesenteric Vein Thrombosis: A Critical Analysis of Thrombocytosis as a Risk Factor
McBane II RD	-	The Impact of Symptom Duration on Plasma Fibrin D-Dimer Analysis in Deep Vein Thrombosis
McCall M	-	Malaria Infection Induced Thrombocytopenia Is not Related to Systemic Platelet Activation
McCarty OJT	-	Evaluation of the Roles of Rac1 and Rac2 in Lamellipodia and Aggregate Formation on Collagen Under Flow
	-	Vav Family Proteins Are Required for Optimal Platelet Spreading on Fibrinogen
	-	Regulation of Spreading in PECAM-1 Knock-Out Mouse Platelets
	-	Comparison of the Role of Protein Kinase C (PKC) in Platelet Spreading on Fibrinogen and Collagen Related Peptide (CRP)
McCarty D	-	Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial
	-	Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH)
McCarty OJT	-	Laminin Stimulates Spreading of Platelets Through a₆b₁-dependent Activation of GPVI
	-	Rho Kinase Regulates Platelet Adhesion and Aggregation on Collagen under Flow
McCarty O	-	Syk Plays a Critical Role in Signalling Downstream of GPVI and Integrin a_IIbb₃, But Is not Required for Efficient G-Protein Mediated Platelet Activation
McClanahan T	-	Paradoxical Example of Warfarin Exerting Anti-Thrombotic Effect without Significantly Altering Template Bleeding Times in Rabbits
McColl MD	-	Clinical and Laboratory Predictors of Recurrent Venous Thrombosis: Interim Results from a Multi-center Prospective Observational Study
McColl B	-	Molecular Pathways for Lymphangiogenesis and Their Role in Human Disease
McCollum D	-	Venous Thromboembolism in Heparin-Treated Patients: How Frequently Is It Associated with Heparin-Induced Thrombocytopenia?
	-	Effects of the Direct Thrombin Inhibitor Argatroban, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia
McColm J	-	Rap1b Is Required for Normal Blood Vessel Formation in Mice
McCormack LJ	-	Clustering of Adipokines and Haemostatic Factors: Evidence for Transcriptional Co-regulation
McCormick AN	-	Thrombin Generation Assay – A Sensitive Tool to Follow the Pharmacokinetics of Factor VIII Replacement Therapy in Haemophilia Patients
McCorquodale S	-	Modified Whole Blood Clotting Time Assay Detects Recombinant Human FVIIa and rFVIIa Analog NN1731 in Canine Hemophilia a Blood in a Dose-Dependent Fashion
McCourt C	-	Development and Evaluation of an Automated Immunoassay for the Determination of D-Dimer on the Abbott AxSYM^® Analyzer
McCrae KR	-	Generation of Kininogen Deficient Mice
McCrae BA	-	Anti-b₂ Glycoprotein I (b₂GPI) and Anti-Annexin A2 Antibodies Stimulate the Release of Microparticles from Endothelial Cells
McCrae KR	-	Anti-b₂ Glycoprotein I (b₂GPI) and Anti-Annexin A2 Antibodies Stimulate the Release of Microparticles from Endothelial Cells
McCrae K	-	Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels
McCrae KR	-	Mechanism of HKa-induced Endothelial Cell Apoptosis
	-	Defining the Interaction between Cleaved High Molecular Weight Kininogen (HKa) and Tropomyosin
McCriskin B	-	Protein Chip Array Profiles in End Stage Renal Disease (ESRD) Patients
	-	Proteomic Profiles in Critically Ill Emergency Department Patients, Utilizing ProteinChip Array Technology
McCullough J	-	Role of Plasma Exchange (PE) in the Treatment of Transplant-Associated Thrombotic Microangiopathy (TM)
McCusker PJ	-	The Canadian Hemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT): Results of the Reliability and Validation Study
	-	A Comparison of the Canadian Hemophilia Outcomes – Kids Life Assessment Tool (CHO-KLAT) and the HaemoQoL
McCusker PJ	-	Immune Tolerance to Factor IX inhibitor
McCutchan A	-	Queensland Health Pathology Service Statewide Coagulation Quality Control Database: the First Three Years Experience
McDermott-Roe CJ	-	Identification of Genes Regulated by Oxidised LDL Acting Through Scavenger Receptor CD36 in Transfected HEK293 Cells
McDonald MK	-	Consideration of HIT Antibody Isotype in Interpretation of the Serotonin Release Assay
McDonald A	-	Case Series of Acquired Factor VIII Inhibitors: Profile in the Australian Capital Territory and Review of Literature
McDonald J	-	Extensive Jugular and Subclavian Vein Thrombosis after Ovarian Hyperstimulation Syndrome as a Complication of In Vitro Fertilization: A Case Report
McDonald MK	-	Novel Dual-Action Anti-Platelet/Anti-Thrombotic Drugs for the Management of HIT
	-	Fish Skins as a Source of Heparin-Like GAGs
McDonald J	-	Laboratory Assessment of von Willebrand Disorder (VWD): Reassessment of ABO-Blood Group, Gender and Age on Laboratory Parameters and the Potential Influence on a Diagnosis of Mild VWD and the Potential Association with Risk of Thrombosis
McDonald MK	-	Arresting Platelet Activation Induced by HIT Antibodies Using a Desulfated Heparin
McDonald A	-	Successful Immune Tolerisation in an Adolescent Severe Haemophilia a Patient with an Inhibitor: A Case Report
McDonnell T	-	Use of Recombinant Activated Factor VII (Novoseven) as Haemostatic Cover for Surgery in Congenital Factor VII Deficiency
McEver RP	-	Lack of P-selectin Glycoprotein Ligand-1 Protects Mice from Thrombosis after Thrombotic Challenges
McEver RP	-	Selectin-Mediated Interactions among Platelets, Leukocytes, and Endothelial Cells
McEwan P	-	Structural Studies of the Factor XI Dimeric Zymogen
McFadden AW	-	Genetic Manipulation of Megakaryocytes to Study Platelet Integrin Regulation
McGlasson D	-	A Multi-instrument Evaluation of a Chromogenic Factor X Assay for Monitoring Oral Anticoagulation Therapy
McGrath M	-	Comparison of Four D-Dimer Tests Combined with Clinical Probability Assessment to Exclude Deep Venous Thrombosis in Symptomatic Outpatients
McGregor JL	-	Identification of Genes Regulated by Oxidised LDL Acting Through Scavenger Receptor CD36 in Transfected HEK293 Cells
	-	Functional Role of Human P-Selectin (CD62P) Polymorphisms in Mediating Cell-Cell Interactions
	-	Gene Expression Comparison Between Monocytes in Culture and Atherosclerotic Laser Microdissected Resident Macrophages
McGregor John, L	-	Investigating an Early Action Gene (6A3-5/hELD/OSA) in PDGF-Treated Human Airway Vascular Smooth Muscle Cells
McGregor JL	-	Macrophage Gene Expression Appears to Differ between AGE and OxLDL Stimulation
	-	MIP-1b and VE-Cadherin Are Implicated in Acute Rejection in Human Heart Transplantation
Mcgregor JL	-	An Early-Activated Gene (6A3-5) Implicated in the Control of Vascular Smooth Muscle Cell Functions
McGrowder D	-	Can the Rotem^® Predict Post-Operative Bleeding and Appropriate Treatment after Cardiac Surgery?
McInerney M	-	Demonstration of Patient Ability to Maintain Long Term Competence Equivalent to Professionals, Utilizing the HemoSense^® INRatio^® System for Home INR Testing
McIntosh JH	-	Could Haemostasis in Haemophilia A Be Normalised by Factor VIII (FVIII) Concentrates at Levels below 1 IU/mL? Studies with Various Methods of Thrombin Generation
McKelvie S	-	Post Treatment Residual Thrombus Is Associated with an Increased Risk of DVT Recurrence, Mortality and a Trend Towards Increased Vascular Death
McKenzie SE	-	The Variability of Platelet Function Testing
McKinnell J	-	Successful Use of FEIBA to Control Postoperative Bleeding after Use of rFVIIa
McKinnon TAJ	-	Loss of Terminal Fucose Expression in Bombay Phenotype Produces Reduced Plasma VWF Level Through a Conformation-Related Increased Susceptibility to ADAMTS-13
McLane MA	-	Alanine Mutagenesis Demonstrates Functional Importance of Four Amino Acids Within the Disintegrin Eristostatin: Implications for Its Anti-Platelet and Anti-Cancer Properties
McLaughlin TJ	-	Pre-Existent Variability in Platelet Response to ADP Accounts FOR ‘Clopidogrel Resistance’
McLean K	-	Tissue Factor Targeted Thrombomodulin (Ab(TF)-TM) – a Novel Tissue Factor Neutralizing Antibody Fused to Thrombomodulin (TM)
Mclean R	-	Results of the Master Lot Calibration of a New Coagulation Monitoring System for Patient Self Testing
	-	INR Results of the CoaguChek® PT Test Compare Well with INR Results of International Reference Thromboplastins
McLean K	-	Tissue Factor-Neutralizing Antibody Fused to Thrombomodulin (Ab(TF)-TM) Has Amplified Anticoagulant Efficacy in a Rat Model of Thromboembolism
	-	Inhibition of Thrombosis after Vascular Injury with a Novel Tissue Factor-Targeted Thrombomodulin Fusion Protein
McLellan D	-	Effect on the Tissue Factor Pathway of Cessation of Warfarin Anticoagulant Therapy
M^cLellan D	-	Influence of the Tissue Factor Pathway on Initiation of Warfarin Anticoagulant Therapy
McLeod S	-	Nanoparticle Tethered Biosensors for Autoregulated Gene Therapy in Hyperoxic Endothelium
McLimont M	-	Results from the Canadian Hemophilia Dose Escalation Prophylaxis Trial: An Update
McLintock C	-	Reversal of the Inhibitory Effect of Monclonal Antiphospholipid Antibodies on Trophoblast Proliferation by Unfractionated Heparin, Low Molecular Weight Heparins (Enoxaparin and Dalteparin) and a Synthetic Pentasaccharide, Fondaparinux
McMahon AD	-	Clinical and Laboratory Predictors of Recurrent Venous Thrombosis: Interim Results from a Multi-center Prospective Observational Study
	-	Fibrin D-Dimer, by Three Different Assays, is an Independent Predictor of Future Stroke in Patients With Atrial Fibrillation
McMillan R	-	Autoimmune Thrombocytopenia: Flow Cytometric Determination of Platelet-associated Autoantibodies against Platelet Specific Receptors
McMillan-Ward EM	-	The Tetraspanin CD63 and Phosphatidylinositol 4-Kinase Type II Co-Localize in Resting Platelets and Are Associated with Lipid Rafts Following Platelet Activation
McNeil HP	-	Serum Amyloid A (SAA) Induces Monocyte Tissue Factor
McRae SJ	-	Evaluation of the Relationship between Free Protein S Levels and Thrombin Generation during Pregnancy
McVey JH	-	Bone Marrow-Derived CD34+ Cells, Modified to Express Anticoagulants on Differentiation, Promote Repair to a Pre-Injured State after Endovascular Injury
	-	Thrombin Is Required for Inflammatory Cell Recruitment and Graft Infiltration During Acute Humoral Xenograft Rejection
McVey JH	-	Platelet Calcium Mobilisation by Recombinant Factor VIIa Is Partially Mediated by Tissue Factor-Dependent Thrombin Generation
	-	Putative Prothrombotic Polymorphisms in Patients with Antiphospholipid Antibodies
McVey JH	-	Reduced Expression of ABCA1 and A Novel Missense Mutation That Results in Altered Protein Trafficking Underlie Scott Syndrome
McVey JH	-	FVII Deficiency due to Homozygous FVII T324M Mutation
ME Mancuso	-	The Detection of Lupus Anticoagulants in Hemophiliacs: The Need for Different Assay Systems
	-	Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients
Meade TW	-	Fibrinogen May Predict Death from Cancer in Men with Lower Extremity Arterial Disease
Meade G	-	A Comparison of the Effects of Shear Stress on the Interactions between Streptococcus sanguis and Staphylococcus aureus with Perfused Human Blood Platelets
Meade TW	-	Risk Factors for Central Retinal Vein Occlusion
Meda P	-	Investigation of Molecular Mechanisms Regulating Fibrinogen Secretion
Medbury H	-	The Opposing Roles of Monocytes in Atherosclerosis
Medbury H	-	The Circulating Progenitor in Intimal Hyperplasia: Could It Be the Fibrocyte?
Medcalf RL	-	Neuroprotective Effects of Oncostatin M in Excitotoxic Injury
	-	t-PA Enhances NMDA-Induced Changes in Free Intracellular Calcium in Individual Neurons
Medina P	-	The C1418T Polymorphism in the Thrombomodulin Gene is Associated with Increased Levels of Circulating Activated Protein C and with Reduced Risk of Venous Thromboembolism
	-	Influence of Polymorphisms in the Endothelial Protein C Receptor Gene on the Risk of Venous Thromboembolism in Carriers of the Factor V Leiden Mutation
Medina P	-	Protein C_Valencia: Symptomatic Type II Protein C Deficiency Associated with a Mutation in the Gla Domain (Glu16 to Lys)
	-	Decreased Plasma Levels of Activated Protein C in Young Survivors of Myocardial Infarction: Relationship with the Extent of Coronary Artery Disease
Medved L	-	Molecular Mechanisms of Thrombin-Mediated Fibrin Assembly
Meesters E	-	Soluble Tissue Factor: A Marker of Microvascular Disease in Patients with Type 2 Diabetes
Meesters EW	-	Cell-derived Microparticles Contain Caspase 3 in Vitro and in Vivo
	-	Laboratory Markers of Cardiovascular Disease in Systemic Lupus Erythematosus: Evidence of a Latent Hypercoagulable State
Megarbane B	-	Prolonged Extracorporeal Life Support (ECLS) in Patients with Severe Membrane Stabilizing Agent (MSA) Poisonings: Hemostatic Management Requires only Minimal Doses of Heparin
Mehran K	-	Thromboembolic Disease and Its Relationship with ABO-Rh Blood-Groups and Other Variables in Patients at Warfarin Clinics in Iran
Mehta P	-	Tissue Factor and Factor VIIa Regulate Expression of Ets-1 in Prostate Cancer
	-	Effects of Daclizumab on Lymphocyte-Endothelial Cell Activity in Patients with Chronic-Graft-Versus-Host Disease
Mehus M	-	Specific Forms of Activated Factor XII in Citrated Plasma Increase Following Percutaneous Coronary Intervention (PCI)
Meier R	-	Role of GPIb, GPIIb/IIIa and Shear on COAT-Platelets Formation
Meier D	-	Cyclosporine Reduces the Platelet Inhibitory Effect of Clopidogrel in Cardiac Transplant Patients
Meijer P	-	Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone^® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel on Risk of Venous Thromboembolism Evaluated through Haemostasis Variables and Sex Hormone Binding Globulin
Meijer K	-	Low CD4/CD8 Ratios In HIV Negative Haemophilia Patients Cause High HCV Viraemia
Meijer AB	-	Functional Duplication of Ligand-Binding Domains within Low-Density Lipoprotein Receptor-Related Protein for Interaction with Alpha2-Macroglobulin, Factor IXa and Factor VIII
Meijer AB	-	Clusters of Ligand-Binding Domains of Low-density Lipoprotein Receptor-related Protein Bind both Heavy and Light Chain of Activated Factor V and Inhibit Cofactor Function
	-	An Antibody Fragment Against Factor VIII That inhibits Factor VIII assembly with von Willebrand Factor and LDL Receptor Family Members
Meijers JCM	-	Hereditary Thrombophilia is not a Risk Factor for Idiopathic Retinal Vein Thrombosis
	-	Acute Hyperglycemia Perturbs Endothelial Glycocalyx and Induces a Prothrombotic State in Healthy Volunteers
	-	Clinical Usefulness of Prothrombin Fragment 1+2 in Patients with Suspected Pulmonary Embolism
Meijers JCM	-	C4b-binding Protein and the Risk of Venous Thrombosis
Meijers JCM	-	Search for Novel Genetic Risk Factors in Venous Thromboembolism: Design of a Family Study
	-	Effects of Clopidogrel on the Rebound Hypercoagulable State in Acute Coronary Syndromes (ACS) Patients after Heparin Discontinuation
	-	Role of Isoleucine Residues 182 and 183 in Thrombin-Activatable Fibrinolysis Inhibitor
	-	Analysis of Blood Coagulation in Mice: Pre-analytical Conditions and Comparison of a Home-made Assay for Thrombin-antithrombin Complexes with Two Commercial Assays
	-	Coagulation in Aviation: Activation of the Coagulation System During Air Travel (The WRIGHT Volunteers Study)
	-	Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Influences the Inflammatory But Not the Procoagulant/Fibrinolytic Response to Escherichia coli-Induced Abdominal Sepsis in Mice
	-	Sustained Factor VIII and vWF Elevation after Total Hip Arthroplasty
	-	Defining Subclinical Phenotypes for Venous Thromboembolism through Measurement of a Hypercoagulable State in Thrombophilic Families
Meijers JCMM	-	SELDI-TOF MS: A Potential High-Throughput Tool for High-Density Lipoprotein Analysis
Meijers JCM	-	Proteomic Analysis of High-Density Lipoprotein
	-	Comparison of Protein Profile Analysis in Patients with and without a History of Venous Thromboembolism: A Pilot Study
	-	The Prognostic Value of the D-Dimer Test in Cancer Patients Treated with and without Low-Molecular-Weight Heparin
	-	Endotoxemia Induces Factor VIII-mediated Resistance to Activated Protein C in Healthy Humans
	-	Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
	-	Naturally Occurring Acute Viral Respiratory Tract Infections in Elderly Patient Results in Increased von Willebrand and Enhanced Fibrinolysis
	-	The Role of PAI-1 Deficiency and a Reduced Capacity to Generate Activated Protein C on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia
Meilleur C	-	Clinical and Laboratory Response to rFVIIa and APCC in a Rare Case of Severe Congenital Factor VII Deficiency with an Inhibitor
Meinders AE	-	Clearance of Plasminogen Activator Inhibitor-1 in Low-Density Lipoprotein Receptor-Related Protein Deficient Mice
Meiring SM	-	A Model of Femoral Arterial Stenosis to Evaluate Anti-platelet Drugs in Baboons
Meiring SM	-	Development of Antithrombotic Antibodies to Human Tissue Factor
Meissner AJ	-	Inherited Thrombophilia (IT) in Patients with Chronic Venous Ulceration (CVU)
Meister S	-	Cerebral Venous Sinus Thrombosis in a 12 year Old Boy with Transient Antiphospholipid Antibodies
Meister S	-	Orthopedic Outcome in Patients With Severe Hemophilia Under Prophylactic Treatment–Benefit of an Early Long-term Prophylaxis?
Meister S	-	12-Year Old Boy with Deep Venous Thrombosis (DVT) and Pulmonary Thromboembolism (PTE)
Melchior C	-	A Gain of Function Mutation in aIIbb3 Results in a Glanzmann Thrombasthenia Phenotype
Melis E	-	P-selectin Antagonist Gallic Acid is Antithrombotic Via Inhibition of Circulating Tissue Factor Deposition in Developing Murine Arterial Thrombi
Mellars G	-	Evaluation of Thirdwave Invader® DNA Analysis Compared to Multiplex PCR Analysis for the Detection of Factor V_Leiden and Prothrombin 3'UTR Gene Mutations
Mellars G	-	A Novel Mutation in the Signal Peptide of the Antithrombin Gene
Melot C	-	Accuracy of Pretest Probability Assessment of Pulmonary Embolism by Junior Physicians Using the Explicit Wells Clinical Model
Melton LJ, III	-	Risk Factors for Venous Thromboembolism (VTE) Among Patients Hospitalized for Major Surgery: A Population-Based Case-Control Study
Melton III LJ	-	Risk Factors for Venous Thromboembolism (VTE) among Patients Hospitalized for Acute Medical Illness: A Population-Based Case-Control Study
Menard J	-	Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone^® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel on Risk of Venous Thromboembolism Evaluated through Haemostasis Variables and Sex Hormone Binding Globulin
	-	Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone^® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel, on Lipids and Inflammation Markers of Arterial Disease
Mendes A	-	Fish Skins as a Source of Heparin-Like GAGs
Mendes-Silva W	-	Antithrombotic Effect of Bothrojaracin, a Bothrops jararaca Snake Venom-Derived (Pro)thrombin Inhibitor
Mendolicchio GL	-	Modulation of Von Willebrand Factor A1 Domain-Mediated Platelet Aggregation by a-Thrombin
Menegatti M	-	Italian Experience in the Assessment of Performance of Clinical Laboratories for DNA Analyses to Detect Three Thrombophilic Mutations
	-	Molecular Characterization in an Italian Patient with Plasminogen Deficiency And Ligneous Conjunctivitis
	-	In vitro Expression Studies and Immunofluorescence Microscopy Analysis of Two Naturally Occurring Mutations on Factor X (FX) Gene (G94R And D95E)
Meng G	-	Treatment with Pasteurized C1 Inhibitor Concentrate in Abdominal Pain Attacks of Patients with Hereditary Angioedema
Meng ZH	-	Hemophilia B Mice Have Delayed Wound Healing
Meng FY	-	The Detection of the Platelet Activation by Flow Cytometry in the Patients with Pre-eclampsia
Menke D	-	Comparative Study of Fibrinolysis Test Systems with A Special Focus on Variable Sample Handling (Different Transport Modalities/Arterial and Venous Catheterization)
Menozzi I	-	Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy
	-	Assessment of Protein S on Hepatopaths at the Last Stage
	-	Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy
Meo A	-	Sickle Cell Disease, Reduced Endothelial Nitric Oxide Synthetase and Total Nitric Oxidase Serum Levels, Abnormal Human Endothelin-1 Release, Vascular Endothelium Suffering and Thromboembolic Risk
	-	Evidences for Vascular Endothelium Damage/Proliferation and Abnormal Neoangiogenesis by Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Interleukin-6 (IL-6) Increased Levels in Sickle Cell Disease
Meola M	-	Genetic and Acquired Risk Factors in Patients with Portal and Mesenteric Venous Thrombosis
Mera V	-	D-Dimer Measurement after Acute Ischemic Stroke Does Not Predict Long Term Outcome Events
Merati G	-	Electrostatic Properties of Naturally Occurring Protein C Mutants by Computational Analysis
	-	Role of Chloride Ions in the Modulation of the Interaction between von Willebrand Factor and Adamts-13
Mercalli V	-	Study of the Role of Membrane Lipid Rafts in Estrogen Signaling in Human Platelets
Mercier B	-	Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients
	-	Age May Modify the Relationship Between Factor V Leiden Mutation: but not G20210A Prothrombin Gene Variation: and Idiopathic Venous Thromboembolism: An Hospital-Based Case-Control Study
Mercier E	-	The Factor V Leiden and Prothrombin 20210G>A Mutations as Risk Factors for Miscarriage during the First Pregnancy: The Matched Case–Control ‘Big NOHA First’ Study
Mercier B	-	Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden
Mercier E	-	Anti-factor V Auto-Antibody after the Use of Recombinant Activated Protein C
Mercier B	-	Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden
Merges C	-	Nanoparticle Tethered Biosensors for Autoregulated Gene Therapy in Hyperoxic Endothelium
Merkel N	-	Long-Term Safety and Efficacy Data on Neonatal Thromboembolism Treated with Dalteparin or Enoxaparin: A Comparison of Once Daily Versus Twice Daily Administration
Merkulov SM	-	Generation of Kininogen Deficient Mice
Merkulova A	-	The 4g/5g Polymorphism of the Pai-1 Gene is Associated with Cerebrovascular Disease Development in Childhood and Juvenile Period
Merlani P	-	Coagucheck aPTT versus Central Laboratory aPTT for Anticoagulation Management after Cardiopulmonary Bypass
Merli GJ	-	Does Body Weight Influence Physician Practices for Providing Venous Thromboembolism Prophylaxis to Acutely Ill Medical Patients? Findings from IMPROVE
	-	Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Intensive Care Units
	-	Physician Practices for Providing Venous Thromboembolism Prophylaxis to Hospitalized Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Meroni PL	-	Platelet Associated Tissue Factor Expression in Patients with Antiphospholipid Syndrome
	-	Impaired Bradykinin Response to Ischemia and Exercise in Patients with Mild Congestive Heart Failure During Angiotensin-Converting Enzyme Treatment. Relationships with Endothelial Function, Coagulation and Inflammation
	-	Toll Like Receptor 4 Is Involved in Antiphospholipid-mediated Thrombosis: In vivo Studies
Merquiol F	-	Anti-fibrinolytic Use in Major Orthopaedic Surgery Reduces Allogeneic Blood Transfusion. A Meta-analysis of Randomised Trials
Merricks EP	-	Modified Whole Blood Clotting Time Assay Detects Recombinant Human FVIIa and rFVIIa Analog NN1731 in Canine Hemophilia a Blood in a Dose-Dependent Fashion
Merrill-Skoloff G	-	Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo
Mertens K	-	Intracellular Assembly of Factor VIII and von Willebrand Factor
	-	Distinct Roles of Basic Residues within the Heparin-Binding Exosite of Factor IX in the Assembly of the Factor X-Activating Complex
	-	Functional Duplication of Ligand-Binding Domains within Low-Density Lipoprotein Receptor-Related Protein for Interaction with Alpha2-Macroglobulin, Factor IXa and Factor VIII
	-	The Contribution of Somatic Mutations in an Antibody against Factor VIII to the Kinetics of Factor VIII Binding and Inhibition of Factor VIII Activity
	-	Clusters of Ligand-Binding Domains of Low-density Lipoprotein Receptor-related Protein Bind both Heavy and Light Chain of Activated Factor V and Inhibit Cofactor Function
	-	An Antibody Fragment Against Factor VIII That inhibits Factor VIII assembly with von Willebrand Factor and LDL Receptor Family Members
	-	The Interface between the EGF2 Domain and the Protease Domain of Activated Factor IX Contributes to Cofactor Binding and Substrate Recognition
Merz M	-	Multicenter Evaluation of a New ELISA for the Determination of Prothrombin Fragment F 1+2
	-	Analytical Evaluation of a Fully Automated Chromogenic Assay for the Determination of Endogenous Thrombin Potential (ETP)
	-	Direct INR Determination by Use of Linear or Orthogonal Regression
Mesa M	-	Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution
Meschengieser SS	-	Retinal Vein Occlusion and Anticoagulation: Does It Offer Any Benefit? Report of Two Cases
Meschengieser SS	-	Hyperhomocysteinemia, Anticardiolipin Antibodies, and Risk for Vascular Access Thrombosis in Hemodialysis Patients
	-	Evaluation of Fibrinolytic Activity and Major Hemorrhages in Probable Type 1 Von Willebrand Disease
	-	Oral Anticoagulation in Patients over 80 Years with Atrial Fibrillation
Meschengieser S	-	Anti Factor VIII Inhibitor: A Single Institution Experience
Messadek J	-	Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases
Messenger SL	-	Possible Role for the Von Willebrand Factor Propeptide in Regulating Von Willebrand Factor Expression
Messenger S	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
Messeri G	-	Managed Hemostasis ‘Point-Of-Care’ Testing in a Large Hospital: A Three-Year Experience and the Assessment of Clotting Tests
Messina M	-	Prophylaxis with Factor VIII Protects Children with Hemophilia a from Inhibitor Development
Messmore HL	-	Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin
Metafratzi Z	-	Assessing Acquired and Inherited Factors in Cases of Idiopathic and Secondary Pulmonary Embolism
Metcalf D	-	Molecular Dissection of Platelet Production Via Random Mutagenesis
Metcalf DG	-	Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function
Metcalfe P	-	Preparation of Reference Materials for the Genetic Diagnosis of Thrombophilia
	-	There Is No Correlation between HPA-1a Antibody Concentration and Clinical Severity of Neonatal Thrombocytopenia in 200 Pregnancies with HPA Alloimmunisation
Mette C	-	Gene Expression Profiling in Antiphospholipid Syndrome Reveals Distinct Molecular Signatures with Diagnostic Value
Metzner H	-	A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates
Meunier S	-	Genetic Study of 16 Women with Decreased FVIII Level and Assessment of Haemophilia a Carrier Status
Meunier S	-	Immune Tolerance with FEIBA in a Severe Haemophiliac B with Inhibitor
	-	Usefulness of Thromboelastography (ROTEM) for Treatment Management in a Severe Deficiency FXIII Patient with Inhibitor
Meyer T	-	Genetic Evidence that CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia
Meyer D	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
Meyer G	-	Is It Safe to Withhold Anticoagulant Therapy in Patients with Negative Results on Spiral CT Pulmonary Angiography?
Meyer D	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
Meyer G	-	Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration
Meyer D	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
Meyer M	-	Identifying the Bleeding Tendency in Patients with Hypo- and Dysfibrinogenemia
Meyer G	-	Diagnostic Value of D-Dimer Assay in Patients with Suspected Pulmonary Embolism: Results in a Multicentre Outcome Study, the ESSEP Study (Evaluation du Scanner Spiralé dans l'Embolie Pulmonaire)
	-	Multi-detector Row Computed Tomography in Outpatients with Suspected Pulmonary Embolism
Meyer D	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
Meyer G	-	Deep Venous Thrombosis in Patients with Acute Pulmonary Embolism: Prevalence, Risk Factors and Clinical Significance
	-	Effect of Age on the Performance of a Diagnostic Strategy Based on Clinical Probability, Spiral CT and Venous Compression Ultrasonography: The ESSEP Study
Meyer D	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Genetic Defects of von Willebrand Factor as a Determinant of Its Survival in the Circulation
	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
Meyer G	-	Inappropriateness of Diagnostic Management in Patients with Suspected Pulmonary Embolism: Frequency, Predictors and Association with Outcome
Meyer D	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
Meyer G	-	Hormone Therapy and Venous Thromboembolism among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens
Meyer D	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
Meyer T	-	CD40 and CD40 Ligand (CD40L) in Primary Hemostasis and Antibody-Mediated Platelet Activation
Meyer G	-	Are Diagnostic Algorithms for Suspected Pulmonary Embolism Applicable in French Emergency Departments?
Meyer D	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Meynard JB	-	Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST Elevation Acute Coronary Syndromes
Mezzano D	-	Activated Human Platelets Synthesize Functional Tissue Factor
	-	Plasma proCPU (TAFI) Concentrations and Clot Lysis Time Are Not Different in a Chilean Population of Young Healthy Individuals Subgrouped According to the Naturally Occurring 325 Thr/Ile Polymorphism
	-	Circulating Platelet-Derived Microparticles in Systemic Lupus Erythematosus: Association with Increased Thrombin Generation and Procoagulant State
	-	Inherited Mucocutaneous Bleeding: Clinical Assessment, Relative Frequency of Diseases and High Prevalence of Bleeders with Normal Laboratory Tests: Prospective Study of 280 Patients and 299 Non Bleeder Controls
Mezzano D	-	Patients with Mucocutaneous Bleeding and Hereditary Disorders of Primary Haemostasis Have Higher Plasma proCPU Levels But a Similar Distribution of the 325 Thr/Ile Polymorphism Compared to Age and Sex Matched Healthy Controls
Mezzasoma AM	-	Detection of a Critical Degree of Platelet TxA₂-Production Inhibition by the PFA100 in Aspirin-Treated Subjects: Possible Relevance for the Monitoring of Aspirin Resistance
MG Rumi	-	Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients
Miao CH	-	Immunomodulation of Transgene Responses Following Naked DNA Transfer of FVIII into Hemophilia A Mice
Miccio M	-	Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism
Michaelides K	-	A Common Ancestral Glycoprotein (GP) IX Gene Mutation (Asn45Ser) Causes Bernard-Soulier Syndrome (BSS) in European Families from Northern Europe and Australia
Michalec L	-	Functional Analyses of the Reconstituted AlphaIIbbeta3 and AlphaVbeta3 Minireceptors
Michalec L	-	Refolding Characteristics of Recombinant Beta₃(109-352) Fragment and Formation of a Functionally Active A-Domain
Michalis LK	-	Antithrombotic Effect of the Peptide YMESRADR, Corresponding to Residues 313–320 of the Platelet a_IIb Subunit in a Rabbit Model of Carotid Artery Thrombosis
Michele MF	-	Pediatric Reference Intervals for Five Coagulation Assays
Michelsen AE	-	Increased Formation of Platelet-derived Microparticles by Heparin
Michelson AD	-	Increased Platelet Activation in Cystic Fibrosis: A Role for cAMP/Adenylate Cyclase But Not for Mead Acid or Platelet CFTR
	-	A Novel Mechanism of Action of Clopidogrel: Inhibition of Monocyte Procoagulant Activity
Michelson AD	-	Pre-Existent Variability in Platelet Response to ADP Accounts FOR ‘Clopidogrel Resistance’
Michelson AD	-	Clinical ‘Aspirin Resistance’ Is Associated with Increased Cyclooxygenase-Independent Platelet Activation
	-	Preconditioning Ischemia Favorably Attenuates Platelet Activation: Insights into Molecular Mechanisms
Michelucci A	-	Prevalence of Inflammatory Gene Polymorphisms in Nonvalvular Atrial Fibrillation Patients
Michetti N	-	Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria
Michiels JJ	-	Characterisation and Classification of Von Willebrand Diseases
Michiels JJ	-	Safe Exclusion of Deep Vein Thrombosis (DVT) by a Normal Rapid ELISA D-Dimeer (<500 Ng/Ml) and by the Combination of a Negative Compression Ultrasonography and a D-Dimer of <1000 Ng/Ml in 1330 Consecutive Outpatients with Suspected DVT in the Primary Care Setting
Micic D	-	Pediatric Thrombosis
Micieli E	-	The Risk of Venous and Arterial Thrombosis in Patients with HIV Infection
Middeldorp S	-	Absolute Risk of Venous and Arterial Thromboembolism Associated with Mild Hyperhomocysteinemia. Results from a Retrospective Family Cohort Study
	-	Comparison of Protein Profile Analysis in Patients with and without a History of Venous Thromboembolism: A Pilot Study
	-	Reliability and Interobserver Variability of the Simplify® D-Dimer Assay for Detecting D-Dimers in Capillary Blood
	-	Incidence of Venous Thromboembolism Among Dutch Airline Pilots
	-	Coagulation in Aviation: Activation of the Coagulation System During Air Travel (The WRIGHT Volunteers Study)
Middeldorp SBüllerHR	-	The Absolute Risk of Venous Thrombosis after Air Travel (WRIGHT Study)
Middeldorp S	-	Defining Subclinical Phenotypes for Venous Thromboembolism through Measurement of a Hypercoagulable State in Thrombophilic Families
	-	Search for Novel Genetic Risk Factors in Venous Thromboembolism: Design of a Family Study
	-	Absolute Incidence of Recurrent Venous Thromboembolism in Patients with Elevated Levels of Factor VIII : c
	-	Incidence of Venous and Arterial Thromboembolism in Asymptomatic Carriers of the Prothrombin 20210A Mutation – A Prospective Cohort Study
	-	A Prospective Cohort Study of Asymptomatic Individuals with Elevated Factor VIII : c to Determine the Absolute Incidence of Venous and Arterial Thromboembolism
Middeldorp S	-	Hereditary Thrombophilia is not a Risk Factor for Idiopathic Retinal Vein Thrombosis
Middeldorp S	-	The Contribution of Cosegregation to the Absolute Risk of Venous Thromboembolism (VTE) in Relatives with Either the Prothrombin G20210A Mutation, High Factor VIII : C Levels or Mild Hyperhomocysteinemia
Mielicki WP	-	Cancer Procoagulant Enhances Tumor Cell Adhesion to the Extracellular Matrix
Miesbach W	-	Clinical Significance of Antiphospholipid Antibodies in Haemophiliacs
	-	Is the Rate of Clinical Manifestations of the Antiphospholipid Syndrome Associated to Cumulative Findings of Antiphospholipid Antibodies?
	-	Clinical Manifestations of Patients with Dysfibrinogenemia
	-	The Additional Presence of Lupus Anticoagulants in 300 Patients with Anticardiolipin Antibodies Increases the Risk of Coincidental Venous and Arterial Thrombosis
Miesbach W	-	The Relation of Laboratory and Clinical Features to the Response to Plasma Exchange Therapy in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Miesbach W	-	Identification of Thrombin Antibodies in Patients with Antiphospholipid Syndrome
	-	Bleeding Events in Carriers Of Haemophilia A – Dependent on the Factor VIII-Activity or the Age of the Carriers?
Miesbach W	-	Inhibitor Development in PTP's: A Retrospective Study in Germany
Miesbach W	-	Rituximab in the Treatment of FXIII Inhibitor Possibly Caused by Ciprofloxacin
	-	Investigations of the Thrombin Generation Test in Patients with FV-L Mutation and Antiphospholipid Syndrome
	-	Manifestations of the Antiphospholipid Syndrome in Patients with Malignancies
	-	Prospective Investigations of the Predictive Value of hs-CRP in Patients with and without the Presence of Antiphospholipid Antibodies
Miesbach W	-	Extensive Venous Malformation Associated with Coagulation Abnormality: Treatment with Peginterferon Alfa 2a
Migliaresi P	-	Cardiovascular Risk Factors and the Risk of Venous Thromboembolism
Mihout B	-	Protein Z Polymorphisms and Cerebral Venous Thrombosis
Mikaelsson M	-	A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates
Mikaszewski B	-	Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients
Mikat-Drozdzynski B	-	Premature Onset of Fetal Loss Is Associated with the Polymorphism of Platelet Membrane Integrin a₂b₁ (a₂807TT)
	-	The IVS1-401 T-Allele of the Estrogen Receptor (ER)-a is an Independent Predictor of Late Fetal Loss
Mikhailenko I	-	Identification of Regions in Low-Density Lipoprotein Receptor-Related Protein Responsible for Interaction with A2 and A1/A3-C1-C2 Portions of Coagulation Factor VIII
	-	Beyond Endocytosis: LRP Function in Cell Migration, Proliferation and Vascular Permeability
Mikovic D	-	Miconazole Oral Gel and Nystatin Solution Potentiates Warfarin Anticoagulant Activity
	-	Combined Genetic Risk Factors in Thrombophilic Serbian Population
Mikulska K	-	Lack of Occult HBV Infection in Polish Haemophilia Patients
Miles L	-	Plasminogen Inhibits Monocyte Apoptosis
Miles SM	-	Factor VIII Residues 97–105 and 1954–1961 of the A1 and A3 Domains Represent an Inter-Subunit Interface
Milillo G	-	Postoperative Pulmonary Embolism Detected by Multi-slice Computerized Tomography (MSCT) after Lung Surgery FcOR Cancer
Milio G	-	Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial
Miljic P	-	Combined Genetic Risk Factors in Thrombophilic Serbian Population
Millanvoye-Van Brussel E	-	The Thrombin-Thrombomodulin Complex Activates Nitric Oxide Synthase 3 through Calmodulin Kinase II and Phosphoinositide 3-kinase Signalling
Millar CM	-	Investigation of Relationship of von Willebrand Factor Antigen Clearance with ADAMTS-13 Activity and Tyr1584Cys Polymorphism in Type 1 von Willebrand Disease
Millar C	-	Blood Leukocyte mRNA Expression of CD34 and VEGFR-2 Is Reduced, But Ve-cadherin and CD14 mRNA Expression Is Increased Following Elective Abdominal Aortic Aneurysm Repair
Millar CG	-	Endothelial Progenitor Cells Are Mobilized Following Coronary Angiography
Millar CM	-	Investigation of Relationship between ADAMTS-13, Von Willebrand Factor Antigen and Collagen-Binding Activity in Patients with Type 1 Von Willebrand Disease
Miller CH	-	Multi-Site Comparison of Platelet Function Testing
Miller R	-	Treatment of HIV Associated Thrombotic Thrombocytopenic Purpura-Importance of Prompt Diagnosis
Miller CH	-	Quality of Life (QoL) Evaluation in Women with Menorrhagia and Inherited Bleeding Disorders
	-	Associations of Factor VIII (FVIII) and von Willebrand Factor Antigen (VWF:Ag) with Race, Age, ABO Blood Group and Co-Morbid Conditions
Miller TN	-	Inhibition of the Catalytic Domain of Factor XIa (FXIac) by the Kunitz Protease Inhibitory Domain of Protease Nexin 2 (PN2KPI) Is Mediated by Interactions Between Lys¹⁹² of FXIac and Pro¹³ of PN2KPI and Between Tyr⁵⁹⁰¹ of FXIac and Arg²⁰ of PN2KPI
Miller TN	-	Macromolecular Substrate-Binding Exosites on Both the Heavy and the Light Chain of Factor XIa Mediate the Formation of the Michaelis Complex Required for Factor IX-Activation
Miller I	-	Protein Profiling of Human Blood Platelets from Young and Aged Individuals
Miller M	-	Thrombophilia Is Not a Risk Factor for Peripheral Intravenous Infusion-Associated Thrombophlebitis
Miller GJ	-	Persistent Hypercoagulability and Risk of Cancer in Older Men
Miller RS	-	Congenital Platelet ADP Receptor (P2Y₁₂) Deficiency: A Case Report
Miller GJ	-	Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study
Miller III	-	Heparin Antibodies in Intensive Care Unit Patients (The HAICU Study)
Miller CH	-	Treatment and Management of Women with Bleeding Disorders and Menorrhagia (WBDM) Study: Laboratory Diagnosis
Miller H	-	Comparative Analysis of Methods for Assessment of Circulating Endothelial Progenitor Cells Indicated Heterogeneity of Subpopulations at Various Stages of Differentiation
Miller CH	-	Clinical and Laboratory Features of Mild Bleeding Disorders (MBD) in Children
Millo JL	-	Local Attenuation of the Protein C Pathway in Patients Developing Pneumonia
Mills N	-	Endothelial Progenitor Cells Are Mobilized Following Coronary Angiography
Milne D	-	Post Treatment Residual Thrombus Is Associated with an Increased Risk of DVT Recurrence, Mortality and a Trend Towards Increased Vascular Death
Milos M	-	Improvement of STA: STACLOT APC-R Test for the Detection of Factor V Leiden by Using APCR Ratio
	-	Is it Possible to Predict the Degree of FVIII Deficiency from aPTT Waveform Analysis on Behring Coagulation Timer (BCT)
Milosevic D	-	A Baltic Origin of the Common ADAMTS13 Mutation 4143insA
Mimuro J	-	Intervention of Plasminogen Activator Inhibitor-1 in Nasal Allergy
Mimuro J	-	Phenotype Correction of Hemophilia A Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene
Mimuro J	-	Aspirin Resistance Detected with Aggregometry Can Not Be Explained by Failure to Suppress Cyclooxygenase Activity: Possible Involvement of Other Signaling Pathway(s) in Cardiovascular Events of Aspirin-treated Patients
Mimuro J	-	Phenotype Correction of Hemophilia a Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene
Minagawa Y	-	Examination of Four Acute Arterial Thrombosis Whose Thrombus Dissolution Treatment by Arterial Catheter was Effective
Miñano A	-	Non-enzymatic Glycation of Antithrombin: Implications in Diabetes Mellitus
	-	Inflammation and Coagulation in Two Models of Endotoxemia in Resistant and Sensitive Mice: Low Relevance of Activation of Coagulation in the Outcome
	-	Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone
	-	Clearance of Latent and Polymeric Antithrombin. Are These Conformational Variants Prothrombotic?
	-	Conformational and Functional Changes in Antithrombin by Oxidation
Minar E	-	Risk Factors for the Postthrombotic Syndrome (PTS)
	-	Prediction of the Risk of Recurrent Venous Thromboembolism by the Activated Partial Thromboplastin Time
	-	Tissue Factor Pathway Inhibitor and the Risk of Recurrent Venous Thromboembolism (VTE)
	-	Complement Component C5a Predicts Future Cardiovascular Events in Patients with Advanced Atherosclerosis
	-	C-Reactive Protein 3'UTR (+1444) C>T Polymorphism in Patients with Spontaneous Venous Thromboembolism
	-	A Positive Family History of Venous Thromboembolism Does Not Predict A High Risk of Recurrence
Minea R	-	Contortrostatin: A Potent Inhibitor of Cancer Growth and Angiogenesis
Minematsu K	-	Identification of Genetic Variations in Genes Comprised in Vitamin K-dependent g-Carboxylation System
Minford A	-	Homozygous Protein C Deficiency in an Affected Fetus – Is There a Case for Early Elective Delivery?
Minh-Muzeaux¹ S	-	The Predictive Value of D-Dimers on the Occurrence of Thromboembolic Events and Death: A Prospective Multicentric Study
Miniati B	-	Inflammatory Markers are Associated with the Abdominal Aortic Diameter
Mintz PD	-	Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels
Minullina I	-	Glycoprotein VI Structure-Function Relationship: Identification of Collagen Binding Domains Using GPVI/FcaR Chimera
Mira Y	-	Protein C_Valencia: Symptomatic Type II Protein C Deficiency Associated with a Mutation in the Gla Domain (Glu16 to Lys)
	-	Influence of Polymorphisms in the Endothelial Protein C Receptor Gene on the Risk of Venous Thromboembolism in Carriers of the Factor V Leiden Mutation
Mirkovic D	-	Homocysteine Levels and MTHFR C677T Genotypes in Patients with Myocardial Infarction under Age 45 years
Miromanova NA	-	Comparative Analysis of the APC Resistance in East Siberian Residences
Miron M-JF	-	Use of D-Dimer (DD) in The Management of Suspected Deep Venous Thrombosis and Pulmonary Embolism in the Emergency Room: Prospective Observations Over 1 year
Miron MJ	-	The VEINES-QOL/Sym Questionnaire Is a Valid and Reliable Measure of Quality of Life in Patients with Deep Venous Thrombosis
Miroslava P	-	Aspirin Induces Receptor Shedding in Platelets by TNFa–Converting Enzyme (TACE)
Mirsamatova G	-	Effects of Base Therapy on Coagulation Haemostasis in Patients with Ischemic Heart Diseases Complicated with Chronic Heart Failure
	-	Role of Endothelial Dysfunction Effect on Coagulation Haemostases in Patients with Chronic Heart Failure
Misiak A	-	Pros and Cons of Rituximab Administration Use in Patient with Immune Thrombocytopenia and Antiphospholipid Antibodies
Mismetti P	-	Anti-fibrinolytic Use in Major Orthopaedic Surgery Reduces Allogeneic Blood Transfusion. A Meta-analysis of Randomised Trials
Mismetti P	-	Clinical Experience with Retrievable ALN Vena Cava Filters
Mismetti P	-	Predictive Factors for Fatal Pulmonary Embolism in 9902 Patients Presenting with an Episode of Venous Thromboembolism. Findings from the RIETE Registry
Misselwitz F	-	Antithrombotic Mechanism of Action of BAY 59-7939 – a Novel, Oral, Direct Factor Xa Inhibitor
	-	Prevention of Venous Thromboembolism with an Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – in Elective Hip Replacement: A Dose-Ranging Study
	-	Interaction of BAY 59-7939 – A Novel, Oral, Direct Factor Xa Inhibitor – with Antiplatelet Agents: Monitoring and Therapeutic Applications
	-	An Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – for Prophylaxis against Venous Thromboembolism after Total Knee Replacement: A Dose-ranging Study
	-	Comparison of the Anticoagulant Properties of BAY 59-7939 – An Oral, Direct Factor Xa Inhibitor – with Fondaparinux and Enoxaparin
Mistrik M	-	Genetic and Phenotypic Analysis of Families with Inherited Hypo- and Dys-fibrinogenemia
	-	Gynaecological Problems in Severe Congenital Factor VII Deficiency
Miszti-Blasius K	-	Lack of P-selectin Glycoprotein Ligand-1 Protects Mice from Thrombosis after Thrombotic Challenges
Mitchell J	-	Plasminogen Inhibits Monocyte Apoptosis
Mitchell LG	-	No Difference in Incidences of Thrombosis between Heparin Bonded Catheters and Non Heparin Bonded Catheters in Infants in the Critical Care Unit Following Surgery for Congenital Heart Disease: A Randomised Controlled Triple Blind Study
Mitchell J	-	Successful Immune Tolerance Induction in a High-Responding Factor VIII Inhibitor Hemophilia a Patient Treated with FVIII/VWF Plasma-Derived Concentrate, Fanhdi®. Cost Effectiveness Analysis
Mitchell CA	-	The Platelet Actin Cytoskeleton Dynamically Reorganizes into Podosomes Upon Cell Adhesion. Identification of a Novel Actin-rich Adhesive Structure in Human Platelets
Mitchell M	-	Absence of Exon V Deleted Factor XI mRNA in Homozygous Factor XI Deficiency
Mitchell LG	-	Comparison of Continuous and Subsampling Methods for Analysis of Thrombin Generation
Mitchell LR	-	Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
Mitchell LG	-	Comparison of the Anticoagulant Effects of Melagatran and LMWH in an Acquired Antithrombin Deficiency in Children with ALL Treated with L-Asparaginase: An Ex Vivo Study
Mitchell L	-	Incorporation of a Comprehensive Pediatric Thrombosis Program as Part of the Multidisciplinary Care Team for Children with Congenital Heart Disease: A Prospective Cohort Study
Mitra N	-	Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function
Mitsugu T	-	Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors
Mitsugu H	-	Fatal Hemorrhagic Disorder and Vascular Intimal Carcinomatosis in Annexin II Expressing Transitional Cell Carcinoma
Mitsuho O	-	Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors
Mittal N	-	Prevalence of Risk Factors for Venous Thromboembolism: A Study from North India
Miura Y	-	Identification of collagen-Binding Region of Platelet Glycoprotein VI (GPVI): Studies Using GPVI/Killer Cell Inhibitory Receptor Chimeric Proteins
Miura Y	-	Analyses of the Interaction of Platelet Collagen Receptor Glycoprotein (GP) VI with Various Types of Collagen
Miyamoto S	-	Rational of Pharmacological Effect of a Combination of FVIIa and FX for Hemophilia with Inhibitors
Miyano K	-	Purification and Characterization of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells
	-	Effects of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells on Endotoxin- or Thromboplastin-Induced DIC in Rats and Concanavalin A-Induced Liver Injury in Mice
Miyashita K	-	Identification of Genetic Variations in Genes Comprised in Vitamin K-dependent g-Carboxylation System
Miyata S	-	Generation and Characterization of ADAMTS13-Deficient Mice
Miyata T	-	Generation and Characterization of ADAMTS13-Deficient Mice
	-	Identification of Genetic Variations in Genes Comprised in Vitamin K-dependent g-Carboxylation System
Miyata S	-	Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice
Miyata K	-	Pharmacological Properties of YM-254890, a Specific Ga_q/11 Inhibitor, on Thrombosis and Neointima Formation in Mice
	-	Evaluation of GPIIb/IIIa Antagonist YM128 Using Monkeys with Photochemically-Induced Middle Cerebral Artery Occlusions
Miyata T	-	Assays for ADAMTS13
Miyazaki H	-	Rational of Pharmacological Effect of a Combination of FVIIa and FX for Hemophilia with Inhibitors
Miyazaki K	-	Molecular Cloning of 20-kDa Myosin Light Chain Isoforms in Human Platelets
Miyazaki T	-	Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies
Miyazawa Y	-	Increased Levels of Hepatocyte Growth Factor in Patients with DIC
Mizukami M	-	Factor VII Arg277His Mutation Induced Discrepancy of Factor VII Activity Levels Using Tissue Factor from Different Sources
Mizukami H	-	Phenotype Correction of Hemophilia A Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene
	-	Phenotype Correction of Hemophilia a Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene
Mälarstig A	-	The -3459 A > GSNP in the CD40L Gene Predicts Plasma Concentrations and Outcome in Patients with Acute Coronary Syndrome (FRISC-II)
	-	The Impact of Tissue Factor Single Nucleotide Polymorphisms on Risk, Outcome and Plasma levels in Acute Coronary Syndrome
Mlzoch L	-	No Major Impact of Prothrombotic Conditions on The Risk of Central Venous Line-Related Thrombotic Events in Children
Mnich J	-	Effect Of BAY 59-7939 – A Novel, Oral, Direct Factor Xa Inhibitor – on Clot-Bound Factor Xa Activity in vitro
Münster M	-	Pilot Study: Aspirin Resistance and/or Platelet Hypersensitivity in Cerebrovascular Disease
Moatti D	-	Expression of TFPIb in Normal Human Tissues and Inhibitory Activity on Tissue Factor-Initiated Coagulation Reactions by Recombinant TFPIb from Transfected CHO Cells and Escherichia Coli
Moazed B	-	Heparins Are Transported Across Rat Gastric Mucosa. Studies in a Verticle Diffusion Chamber
Moberg L	-	Tissue Factor Is Associated with a Negative Outcome of Clinical Islet Transplantation
Mochizuki S	-	Purification and Characterization of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells
Mocking AIM	-	Glucose Uptake Via GLUT3 in Human Platelets Is Regulated Via PKB
	-	Inhibition of Collagen-Induced Thrombus Formation by Insulin Is Absent in Diabetes Mellitus Type 2
	-	Impaired Insulin Signaling in Platelets from Patients with Diabetes Mellitus Type 2
Modarai B	-	Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Resolution
Modarai B	-	Monocyte Recruitment and Increased Urokinase (uPA) Activity are Important for Thrombus Resolution
Modis L	-	Impaired Healing of Cutaneous Wounds in Factor XIII-Deficient Mice
Moebius J	-	Glycosylation Site Analysis of Human Platelet Proteins
Moebius J	-	An Approach to Elucidate the Platelet Membrane Proteome
Moeller F	-	Uremia-specific Effect on the Arterial Media during Development of Uremic Atherosclerosis in apolipoprotein-E Deficient Mice
Moers A	-	Platelets in Atherothrombosis: Lessons from Mouse Models
Moessmer G	-	Hypothetic Genetic Risk Factors for Preeclampsia or HELLP Syndrome: Probabilities of Risk Factors Present in Fetuses Derived from the Genotypes of the Parents
Mogami H	-	Protein S Suppresses Invasive Potential of THP-1 Cells by Lowering Binding Capacity of Plasminogen on Cell Surface
Mogielnicki A	-	Angiotensin 1–9 (Ang-1-9), Similarly to Angiotensin II (Ang II), Increases Blood Pressure and Enhances Thrombosis in Hypertensive Rats
Mohamed S	-	Anti-Inflammatory and Anticoagulant Effects of Atorvastatin in Type 2 Diabetics Versus Non-Diabetics
	-	Statin Beyond Lipid Lowering: Statins and Angiogenesis-Mediated Processes
Mohammad Ali G	-	Thromboembolic Disease and Its Relationship with ABO-Rh Blood-Groups and Other Variables in Patients at Warfarin Clinics in Iran
Mohan JS	-	Plasma Levels of Tissue Factor and Soluble E-Selectin in Sickle Cell Disease: Relationship to Genotype and to Inflammation
Mohanlal R	-	The Effect of a Second Generation Inhibitor of p38 MAP Kinase on Platelet Function
Mohanty D	-	Prevalence of Thrombophilic Mutations and Polymorphisms in Cases of Recurrent Pregnancy Loss (RPL)
	-	VWF1 Andvwf2 Alleles (Intron 40) Are Suitable Markers for Carrier Detection and Antenatal Diagnosis in VWD Families in Indian Population
	-	Prevalence of type 2N von Willebrand Disease in Indian VWD patients
	-	Thrombophilia Markers in Cases of Inflammatory Bowel Disease (IBD)
Mohl A	-	Modeling VWF Catabolism Predicts the Multimer Pattern and Subunit Degradation in VWD Vicenza, Type 1, Type 2A, and Healthy Controls after DDAVP Infusion
Mohn AC	-	Prolonged Thromboprophylaxis with Dalteparin May Improve Survival in Patients Operated on for Abdominal Cancer
Mohri H	-	Molecular Cloning of 20-kDa Myosin Light Chain Isoforms in Human Platelets
Moia M	-	Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia
	-	Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism
	-	Conjoint Analysis to Elicit Preferences on Anticoagulant Treatment in Patients Receiving Vitamin K Antagonists (VKA)
	-	Oral Surgery in Patients on Oral Anticoagulant Therapy: A Randomized Comparison of Different INR Targets
	-	Quality of Life (QoL) in Patients Receiving Vitamin K Antagonists (VKA): A Study Using EQ-5D Questionnaire
	-	A Prospective Registry on the Long-Term Clinical Outcome of Venous Thromboembolism (Multicenter Advanced Study for a ThromboEmbolism Registry – MASTER): Description of the study cohort
Mokrej[scaron] MUDr. J	-	The Monitoring FEIBA Therapeutic Effect in a Haemophiliac with an Inhibitor by the Method of Thrombelastography
Molinari AC	-	Hemostatic Alterations in Pediatric Leukemias
Molinatti M	-	Management of the Patients on Long Term Oral Anticoagulant Treatment (OAT) Undergoing Elective Surgery: Experience of the Italian Anticoagulation Clinics
Mollica L	-	Regulation of Human Endothelial Cell Protein C Receptor (hEPCR) Gene Expression
Mollica L	-	Characterisation of Anti-ADAMTS13 Autoantibodies from a Patient with Thrombotic Thrombocytopenic Purpura (TTP)
Molliex S	-	Anti-fibrinolytic Use in Major Orthopaedic Surgery Reduces Allogeneic Blood Transfusion. A Meta-analysis of Randomised Trials
Mombelli G	-	Variation in Coagulation Inhibitors During Prolonged Sitting: Possible Pathogenetic Mechanisms for Travel-associated Thrombosis
Momi S	-	NCX-6550, a Nitric Oxide-Donating Derivative of Pravastatin, Prevents Thrombus Formation and Inhibits Intimal Thickening in Hypercholesterolemic Mice more than Pravastatin, Despite Identical Lipid Lowering
	-	Evidence Suggesting That Activated Platelets Induce APC-Resistance in Vivo
	-	Deficiency of Matrix Metalloproteinase-2 (MMP-2) Impairs Platelet-Dependent Haemostasis in Mice
Monagle P	-	Tissue Factor Pathway Inhibitor (TFPI) during Heparin Therapy in the Paediatric Intensive Care Unit (PICU)
	-	Multi Modal Management of Purpura Fulminans due to Homozygous Protein C Deficiency
	-	Developmental Haemostasis and Response to Heparin Therapy in Children
Monagle P	-	Tissue Factor Pathway Inhibitor (TFPI) during Cardiopulmonary Bypass (CPB) in Children
Monagle P	-	Chromogenic and Clot Based Protein C Assays Contribute to the Management Of Homozygous Protein C Deficient Patients
	-	Brachial Artery Thrombosis in Infants: A Multidisciplinary Algorithm for Limb Salvage
Monagle P	-	Incidence of Major Bleeding in a Large Paediatric Cohort of Patients Requiring Warfarin Therapy
	-	Tissue Factor Pathway Inhibitor (TFPI) Contributes to the Early Anticoagulant Effect of Unfractionated Heparin (UFH) during Haemodialysis
	-	Optimising Anticoagulant Management Strategies through the Use of Validated Educational Interventions
	-	Clotting Factor Prophylaxis in Boys with Haemophilia; Experience from a Single Australian Centre
	-	Heparin Monitoring During Haemodialysis in Children
	-	Monitoring Haemostasis in Cardiopulmonary Bypass in Children – Measures of Heparin Activity
	-	Platelet Changes during Cardiopulmonary Bypass in Children
Monahan PE	-	Recurrent Hemarthroses Halted by Sequential Therapy with Activated Prothrombin Complex Concentrate (aPCC) and Recombinant Factor VIIa
Mondorf W	-	Self-assessment of Bleeding in Young Women – Results from a Multicenter Questionnaire
Mondorf C	-	Self-assessment of Bleeding in Young Women – Results from a Multicenter Questionnaire
Mondorf C	-	Monitoring of D-Dimer and Anti-Xa Activity in 43 Women Treated with Dalteparin During Pregnancy
Mondorf W	-	Monitoring of D-Dimer and Anti-Xa Activity in 43 Women Treated with Dalteparin During Pregnancy
Mondorf W	-	Home Treatment Diaries: Evaluation of a Handheld Communicator Brand Electronic System for the Documentation of Hemophilia Therapy
Monego G	-	Polymorphonuclear Leukocytes Express Tissue Factor after Activation with P-Selectin
Moneti G	-	Interaction of Choline/Betaine Metabolysm and Homocysteine Plasma Levels
Mongolwongroj P	-	Changes in Thrombogenic Markers but not Factor XIII in Left Atrium of Thai Patients with Mitral Stenosis
Monk S	-	Laboratory Investigation for Lupus Anticoagulant (LA) Experience of a Large General Hospital
Monkhouse L	-	Evaluation of DiaMed Heparin/PF4 Testing for HIT
Monopoli A	-	NCX-6550, a Nitric Oxide-Donating Derivative of Pravastatin, Prevents Thrombus Formation and Inhibits Intimal Thickening in Hypercholesterolemic Mice more than Pravastatin, Despite Identical Lipid Lowering
Monreal M	-	Predictive Factors for Fatal Pulmonary Embolism in 9902 Patients Presenting with an Episode of Venous Thromboembolism. Findings from the RIETE Registry
	-	Does Body Weight Influence Physician Practices for Providing Venous Thromboembolism Prophylaxis to Acutely Ill Medical Patients? Findings from IMPROVE
Monreal Y	-	Inflammation and Coagulation in Two Models of Endotoxemia in Resistant and Sensitive Mice: Low Relevance of Activation of Coagulation in the Outcome
Monreal M	-	Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: Do Perceived Risk Factors for Bleeding Influence Physicians' Practices? Findings From the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
	-	The Influence of Previous or Currently Active Cancer on Venous Thromboembolism Prophylaxis Prescribing Practices in Acutely Ill Medical Patients
Monroe DM	-	FIX Activation on the Surface of Activate Platelets by rFVIIa in the Absence of Tissue Factor
Monroe DM	-	Hemophilia B Mice Have Delayed Wound Healing
	-	Cell-Based Models of Haemostasis
Montaner J	-	Deleterious Effect of the Common FXIII Val34Leu Polymorphism in Patients with Ischemic Stroke Treated with Fibrinolytic Therapy
Montanya E	-	Effect of Cigarrette Smoking on Fibrinogen and Von Willebrand Factor and Their Association with Risk Factors for Microangiopathy
Monteiro R	-	Glycoprotein VI Structure-Function Relationship: Identification of Collagen Binding Domains Using GPVI/FcaR Chimera
Monteiro RQ	-	Antithrombotic Effect of Bothrojaracin, a Bothrops jararaca Snake Venom-Derived (Pro)thrombin Inhibitor
Montes R	-	EPCR Cleavage and inactivation by Neutrophil Proteinase 3
Montgomery R	-	Normal VWF Synthesis and Processing in Patients with Decreased Plasma Survival of C6536T Variant VWF
Montgomery J	-	A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
Montgomery RR	-	Murine Hemophilia A is Phenotypically Corrected by Platelet-Expressed Factor VIII Even in the Absence of Detectable Plasma FVIII
Montgomery RR	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
Montgomery RR	-	Platelet-Derived Factor VIII (FVIII) Is Protected from Inhibitor Inactivation – A Potential Approach for Gene Therapy of Hemophilia A with Inhibitors
Montgomery R	-	A Missense Mutation in Exon 28 (C4120T) of the Von Willebrand Factor Gene is the Cause for Von Willebrand Disease in a Large Amish Pedigree
Montinari MR	-	Anti-Angiogenic Action of Peroxisome Proliferator-Activated Receptor(PPAR)g Ligands Through Cox-2-Mediated MMP-9 Expression and Release
Monzini M	-	Conjoint Analysis to Elicit Preferences on Anticoagulant Treatment in Patients Receiving Vitamin K Antagonists (VKA)
Monzini MS	-	Differences between Patients’, Physicians’ and Pharmacists’ Preferences for Treatment Products in Hemophilia. A Discrete Choice Experiment
Monzini M	-	Quality of Life (QoL) in Patients Receiving Vitamin K Antagonists (VKA): A Study Using EQ-5D Questionnaire
Moog P	-	TFPI Degradation by Neutrophil Proteases: Potential Implications in Acute Myocardial Infarction
Mooney S	-	Identifying Hemostatic Modifier Loci Ameliorating FVII-Insufficiency Using Phenotypic Differences between Strains
Moore AS	-	Highly Sensitive and Specific Test Panel Results in an Improved Laboratory Diagnosis of the Lupus Anticoagulant 1998–2004
Moore PJ	-	Highly Sensitive and Specific Test Panel Results in an Improved Laboratory Diagnosis of the Lupus Anticoagulant 1998–2004
Moore NR	-	A Model Thrombus System for Assessing Thrombolysis
	-	Regulation of Model Thrombus Lysis by TAFIa, PAI-1 and a₂-Antiplasmin
	-	a₂-Antiplasmin Interaction with Endothelial Cells Via Integrins
Morais S	-	The Spectrum of Mutations and Molecular Pathogenesis of Haemophilia A in 163 Portuguese Patients
Morales M	-	Inherited Mucocutaneous Bleeding: Clinical Assessment, Relative Frequency of Diseases and High Prevalence of Bleeders with Normal Laboratory Tests: Prospective Study of 280 Patients and 299 Non Bleeder Controls
Moran N	-	Accurate RNA Transcript Profiling of Platelets from Clinically Relevant, Small Blood Volumes
	-	Occupancy-Dependent Interaction Between Platelet Integrin a_IIbb₃ and ICln
	-	Determining a Functional Association Between the Integrin LFA-1 and the Volume Regulating Protein ICln in Lymphocytes
	-	Proteomic Analysis of The Low Molecular Weight Platelet Secretome Reveals the Presence of Novel N-Terminal Thrombospondin-1 Fragments
Moran B	-	Integrin As Scaffold
	-	Introduction of Thromboelastography for Monitoring Haemostatic Function during Pseudomyxoma Peritonei Surgery
Moran N	-	A Novel Integrin a_IIbb₃-Associating Protein in Platelets
Morange P	-	Polymorphism A36G of the Tumor Necrosis Factor Receptor 1 Gene Is Associated with HDL Cholesterol, TNFR1 and PAI-1 Levels in Obese Women
Morange PE	-	TAFI Gene Polymorphisms and Plasma TAFI Levels: A Trans-Ethnic Association Study
Morange PE	-	Haemostatic Factors and the Risk of Cardiovascular Death in Patients with Coronary Artery Disease: The AtheroGene Study
	-	Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
Morange PE	-	Low Platelet Response to Clopidogrel Increased the Risk of Recurrent Atherothrombotic Events in Patients with Non-ST Acute Coronary Syndrome after Coronary Stenting
Morano S	-	Central Venous Catheters Related Thrombosis in Hematological Patients
Moratelli S	-	Inherited Bleeding Disorders: The Emilia-Romagna Region Register, 2004 Update
Morawski W	-	Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism
Morboeuf O	-	Soluble Endothelial Protein C Receptor (sEPCR) Levels, A3 Haplotype of EPCR Gene and the Risk of Thrombosis in Carriers of Antithrombin (AT), Protein C (PC) and Protein S (PS) Defects
	-	Prevalence and Clinical Significance of IgG and IgM Anti-Protein S (aPS) and Anti-Annexin V (aAV): Retrospective and Prospective Analysis of the WAPS Study
	-	Soluble Endothelial Protein C Receptor Levels (sEPCR) and Thrombotic Manifestations in Carriers of Dysfunctional Protein C Variants
Mor-Cohen R	-	Substitutions of Cysteine Residues in b3 Affect aIIbb3 Integrin Processing and Activation
Moreira I	-	The Spectrum of Mutations and Molecular Pathogenesis of Haemophilia A in 163 Portuguese Patients
Morel-Kopp M-C	-	Discrepancies between the Overall Coagulation Potential (OCP) Assay and International Normalised Ratio (INR) in Warfarin-Treated Patients
Morel-Kopp MC	-	Functional Analysis of Obligate Heterozygous Defects in Platelet Glycoprotein (GP) Ib-V-IX in Velo-Cardio-Facial Syndrome (VCFS) Patients
Morel-Kopp M-C	-	Measurement of Platelet Function in Response to 3 Common Antiplatelet Regimens in Patients with Peripheral Occlusive Arterial Disease (POAD)
Morel-Kopp MC	-	A Common Ancestral Glycoprotein (GP) IX Gene Mutation (Asn45Ser) Causes Bernard-Soulier Syndrome (BSS) in European Families from Northern Europe and Australia
Morel-Kopp M-C	-	Use of a Functional Assay to Diagnose Protein S Deficiency; Increasing Testing of Obstetric Patients Yields Unreliable Results
Morelli VM	-	Hemostatic Changes in Patients with Malaria
Morelli VM	-	ABO Blood Group Genotypes and the Risk of Venous Thrombosis: Effect of Factor V Leiden
Morelli O	-	Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement
Morelli A	-	Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement
Morelli B	-	Clinical Evaluation of Thromboembolic Samples with the New HemosIL™ D-Dimer HS and the HemosIL™ D-Dimer Assays on the ACL TOP
Morelli VM	-	The Behavior of Anticardiolipin Antibodies Levels in Patients with Venous Thromboembolism
Morelli VM	-	The Effect of ABO Blood Group Genotypes on the Loading of von Willebrand Factor with A and B Antigens
Morello M	-	Oral Contraceptives in the Management of Rare Coagulation Bleeding Disorders
Moret EE	-	The Contribution of Somatic Mutations in an Antibody against Factor VIII to the Kinetics of Factor VIII Binding and Inhibition of Factor VIII Activity
Morfini M	-	Pharmacokinetics, Efficacy and Safety of Solvent/Detergent (S/D) Treated Plasma in Patients with Rare Inherited Coagulation Disorders (RICDs)
Morfini M	-	Long Term and Low Dose Prophylaxis with rFVIIa in Patients Affected by Congenital Bleeding Disorders
Morgan G	-	Prevention of Canine Coronary Artery Thrombosis by the von Willebrand Factor Antagonist, GPG290
Mori T	-	Stellate Cells Produce ADAMTS13 in Human Liver
Mori S	-	Cobra Cardiotoxins, Members of the Ly-6 Protein Family, Specifically Bind to Integrin alphavbeta3
Moriarty R	-	Development of a Mouse Serum Protein Map for Proteomic Research
Moricone A	-	Hypercoagulability May Predict Embryo Implantation after Assisted Reproductive Procedures
Morishima Y	-	Recombinant Factor VIIa Reverses Te Prolonged Bleeding Time Induced B A High Dose of DU-176b, a Novel Direct Factor Xa inhibitor, In Rats
Morishima Y	-	Pharmacological Characterization, Antithrombotic and Bleeding Effects of DU-176b, a Novel, Potent and Orally Active Direct Inhibitor of Factor Xa: A Wider Safety Margin of Antithrombotic and Bleeding Effects Compared to Heparin, LMWH and Warfarin
Morishima Y	-	Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents
Morishima Y	-	Antithrombotic Effects of a Direct Factor Xa Inhibitor, DU-176b, and an Antithrombin Dependent Factor Xa Inhibitor, Fondaparinux, on an Ex vivo Capillary Perfusion Chamber Thrombosis Model in Rats
Morishita K	-	Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo
Morishita E	-	Functional Analysis o Two Recombinant Missense Mutant Factor XI, F221S ad C212R
Morishita E	-	HMG-CoA Reductase Inhibitors Reduce the Synthesis of Tissue Factor and Factor VII and Increase the Synthesis of Tissue Factor Pathway Inhibitor in Human Mononuclear Cells
Morison IM	-	A New Form of Familial Thrombocytopenia Associated with a Mutation of Cytochrome C
Morita T	-	Identification of Heparin-Binding Region of Snake Venom VEGF (VEGF-F) and Its Blocking Effect on VEGF-A165
	-	A Calcium-dependent Anti-human Coagulation Factor IX Monoclonal Antibody That Recognizes Phospho-serine (158) of the Activation Peptide Region
	-	Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets
	-	C-terminal Heparin-Binding Peptide of Snake Venom VEGF Specifically Blocks VEGF-stimulated Endothelial Cell Proliferation
	-	Molecular Cloning of Novel Vascular Endothelial Growth Factors from Snake Venoms
Moritani Y	-	Evaluation of GPIIb/IIIa Antagonist YM128 Using Monkeys with Photochemically-Induced Middle Cerebral Artery Occlusions
	-	Pharmacological Properties of YM-254890, a Specific Ga_q/11 Inhibitor, on Thrombosis and Neointima Formation in Mice
Moritz P	-	A Normal D-dimer and a Low Clinical Probability Test Safely Excludes Venous Thromboembolism. A Follow-up D-dimer Adds No Further Information
Morken B	-	Markers of Vascular Inflammation Are Associated with the Degree of Atherosclerosis Assessed as Angiographic Score and Treadmill Walking Distance in Patients with Peripheral Arterial Occlusive Disease
Moroi M	-	Identification of collagen-Binding Region of Platelet Glycoprotein VI (GPVI): Studies Using GPVI/Killer Cell Inhibitory Receptor Chimeric Proteins
Moroi M	-	The Rap1 Activation Mechanism in Platelets: It is Related to the Release Reaction Mediated Through the Collagen Receptor Glycoprotein (GP) VI
Moroi M	-	Analyses of the Interaction of Platelet Collagen Receptor Glycoprotein (GP) VI with Various Types of Collagen
Moroni B	-	Factor VIII and von Willebrand Factor Changes after Desmopressin and During Pregnancy in Type 2M von Willebrand Disease Vicenza: A Prospective Study Comparing Patients with Single (R1205H) and Double (R1205H-M740I) Defect
	-	TAFI 325/Ile Genotype in Old Population of Northern Italy
Moroose R	-	Successful Use of Bivalirudin in the Treatment of Patients Suspected, or at Risk of, Heparin-Induced Thrombocytopenia
Morosov Yu	-	Heparin-induced Thrombocytopenia in Patients after Extracorporeal Circulation Surgery
Morozov Yu	-	Oxidized Fibrinogen Affects Blood Rheology (in vitro Study)
	-	Diagnostic Importance of C-Reactive Protein and D-Dimer in Critically Ill Patients
Morra E	-	Automated VWF : RCo for VWD Diagnosis
	-	Management of the Patients on Long Term Oral Anticoagulant Treatment (OAT) Undergoing Elective Surgery: Experience of the Italian Anticoagulation Clinics
Morris MA	-	A Second Swiss Family with Upshaw-Schulman Syndrome (Hereditary Thrombotic Thrombocytopenic Purpura, TTP): Clinical Course and Molecular Findings
Morris RJ	-	Haemostatic and Haemodynamic Responses to Different Intermittent Pneumatic Compression (IPC) Protocols used for Prophylaxis against Deep Venous Thrombosis (DVT)
Morris TA	-	Abnormal Kinetics of Fibrinolysis in Patients with Chronic Thromboembolic Pulmonary Hypertension
Morrison L	-	A New Double Virus Inactivated 4-Factor Prothrombin Complex Concentrate (4F PCC)
Morrison ER	-	Altered Clearance of Apoptotic Endothelial Cells in the Presence of Antiphospholipid Antibodies Provides a Dual Mechanism for Thrombosis in Antiphospholipid Syndrome
Morrissey J	-	Influence of the Tissue Factor Pathway on Initiation of Warfarin Anticoagulant Therapy
Morrissey JH	-	Tissue Factor: Lack of the Cytoplasmic Tail Results in Generation of Functional Microparticle-Associated Tissue Factor
Morrissey J	-	Effect on the Tissue Factor Pathway of Cessation of Warfarin Anticoagulant Therapy
Morser J	-	Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Regulates Activated Complement C5a in vivo
Morser Kira	-	Investigating an Early Action Gene (6A3-5/hELD/OSA) in PDGF-Treated Human Airway Vascular Smooth Muscle Cells
Morstabilini G	-	A Telemedicine Project for Managing Patients on Oral Anticoagulant Therapy
Mosch G	-	Development and Clinical Evaluation of Two Chromogenic Substrate Methods For Monitoring Fondaparinux Sodium
Mosena L	-	Increased Risk of Recurrent Venous Thromboembolism in Patients with Deep-Vein Thrombosis Who Are Carriers of the Factor V Leiden or Prothrombin Gene Mutation. A Meta-Analysis
Moser M	-	Enhanced Blood Coagulation and Fibrinolysis in Mice Lacking Histidine-Rich Glycoprotein/HRG
Moses JW	-	Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease – A Multi-Center Feasibility Study
Mosesson MW	-	Cell Death Induced by Fibrin-Degradation Products
Mosesson MW	-	Fibrinogen and Fibrin Structure and Functions
Mosheimer BA	-	Inhibition of Monocyte-induced Procoagulant Activation with Antithrombin
	-	Expression and Function of Syndecan-4 in Human Platelets: A Prominent Role for Antithrombin
Moshonov J	-	Autologous Bone and Marrow Grafted within a Clot of Platelet Rich Plasma Construct Normal Viable Bone
Mosnier LO	-	Modulation of Endothelial Protein C Receptor (EPCR)-Dependent Protein C Activation and Activated Protein C Cytoprotective Activity By Platelet Factor 4
Mosqueda-Garcia R	-	Dose-Related Inhibition of Factor Xa in Healthy Subjects by Razaxaban, an Orally-Active Selective Factor Xa Inhibitor
Moss M	-	Soluble CD40L in Peripheral Artery Disease: Relationship with Disease Severity, Platelet Markers and the Effects of Angioplasty
Mosseri E	-	Dynamic Responsiveness to Aspirin in Patients Undergoing PCI
Mosseri M	-	Dynamic Responsiveness to Aspirin in Patients Undergoing PCI
Mostad H	-	Aspirin Resistance: Platelet Resistance not Non-Compliance
Mostarda G	-	Management of the Patients on Long Term Oral Anticoagulant Treatment (OAT) Undergoing Elective Surgery: Experience of the Italian Anticoagulation Clinics
	-	Automated VWF : RCo for VWD Diagnosis
Mota R	-	Inflammation and Coagulation in Two Models of Endotoxemia in Resistant and Sensitive Mice: Low Relevance of Activation of Coagulation in the Outcome
Mota APL	-	Increased Plasma Levels of Lipoprotein(a) Correlate with Severity of Angiographically Defined Coronary Artery Disease
Mottier D	-	Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden
	-	Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden
	-	Recurrent Venous Thrombo-Embolism in Cancer Patients: Data from a Hospital-Based Case-Control Study
	-	Fibrinogen-Aa Thr 312 Ala and Factor XIII Val 34 Leu Polymorphisms in Idiopathic Venous Thromboembolism
	-	Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Drug Use and the Risk of Venous Thromboembolism: Results of an Ongoing Hospitalized-Based Case–Control Study
	-	Age May Modify the Relationship Between Factor V Leiden Mutation: but not G20210A Prothrombin Gene Variation: and Idiopathic Venous Thromboembolism: An Hospital-Based Case-Control Study
	-	Effect of Age on the Performance of a Diagnostic Strategy Based on Clinical Probability, Spiral CT and Venous Compression Ultrasonography: The ESSEP Study
	-	Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients
	-	Soluble CD146 in Women with Unexplained Pregnancy Loss: A New Insight. A Paired Case–Control Study
	-	Supperiority of Intermittent Pneumatic Compression of the legs over Elastic Stockings to Prevent Venous Thrombosis in Patients with Acute Intra-Cerebral Hemorrhage: A Randomized Trial
Motto D	-	Sustained Platelet Adhesion and VWF String Formation in Stimulated Venules Of Adamts13-/- Mice
Motto D	-	Additional Environmental and Genetic Factors Are Required to Trigger TTP in ADAMTS13-Deficient Mice
Motto D	-	Activated Factor XI Cleaves von Willebrand Factor in the A2 Domain: A Possible Role of FXIa Along with ADAMTS13 in the Etiology of TTP
	-	Recombinant ADAMTS13 Refractory to Suppression by TTP Inhibitors
Moukhametova LI	-	Fibrin-Monomer Prepared Using Thrombin-Like Enzyme from Snake Venom Agkistrodon Halys as Stimulator of Plasminogen Activation By t-PA
Moukhametova LI	-	Activation Kinetics of Glycoform of GLU-Plasminogen and Lys-Plasminogen by Plasmin-Staphylokinase Complex
Mouquet F	-	Plasma Levels of Tissue Factor and von Willebrand Factor Predict Long Term Clinical Outcome after Percutaneous Coronary Revascularization
Mouret P	-	ASA and NSAIDs with Melagatran/Ximelagatran or Enoxaparin Do NOT Increase Bleeding in Patients Undergoing Joint Replacement Surgery. The METHRO III Study
Mourits-Andersen T	-	Alterations of the Tissue-Factor Induced Pathway of Coagulation during Acute Deep Vein Thrombosis (DVT): Significant Increase in Tissue-Factor Pathway Inhibitor (TFPI)
	-	Lupus Anticoagulant (LA) is Significantly Associated with Inflammation Among Patients Suspected for Deep Vein Thrombosis (DVT)
Mousa AS	-	Discovery of Angiogenesis Inhibition by Natural Products Derived from Garlic: Potential Anti-Cancer Benefits
Mousa SA	-	Discovery of Angiogenesis Inhibition by Natural Products Derived from Garlic: Potential Anti-Cancer Benefits
	-	Anti-Inflammatory and Anticoagulant Effects of Atorvastatin in Type 2 Diabetics Versus Non-Diabetics
Mousa S	-	Synergistic Effect of Melagatran on the Antiplatelet Efficacy of the Platelet GPIIb/IIIa Receptor Antagonist Eptifibatide or Abciximab in Inhibiting Collagen-induced Platelet Aggregation
Mousa SA	-	Statin Beyond Lipid Lowering: Statins and Angiogenesis-Mediated Processes
	-	The Hemostatic State in Cancer Patients: The Relationship Between Hypercoagulable Markers and Cancer Prognostic Markers
Mowinckel M-C	-	Decreased Anticoagulant Response to Recombinant Tissue Factor Pathway Inhibitor (TFPI) in Pooled Normal Plasma with IgG Fractions from Patients with Lupus Anticoagulant is Associated with Increased Thrombin Generation
	-	Dose-Dependent And Differential Effects of Two Doses of Continuous Combined Hormone Replacement Therapy (HRT), Tibolone And Raloxifene on Markers of Coagulation Activation
Mozzoli M	-	Circulating Tissue Factor Activity Is Increased by Hyperglycemia and Hyperinsulinemia in Normal Human Subjects
Mu Y	-	Haemostatic Characters during Liver Transplantation with Preoperative DIC
Mu F	-	Regulation of Platelet Receptors
Muchitsch E-M	-	Protective Effect of Human Plasma-Derived Protein C in Septic Neonatal Mice
Muchitsch E-M	-	Kinetics of in vivo Activation of Protein C In Healthy Animals
Muchova J	-	Does Pycnogenol Intensify Efficacy of Acetylsalicylic Acid in the Inhibition of Platelet Function?
Muddiman DC	-	Agonist Dependence of the Platelet Secretome
Mueck W	-	Aspirin Has No Effect on the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY 59–7939 – An Oral, Direct Factor Xa Inhibitor
Muench E	-	Predictive Value of ISTH DIC-Score and aPTT Waveform Analysis at Admission to the ICU
	-	Platelet Contractile Force and Clot Elastic Modulus Measured by Hemodyne Apparatus in Intensive Care Unit Patients: Identification of Patients with High Bleeding Risk
Mugelli A	-	Asymmetric Dimethyl Arginine (ADMA), Homocysteine and Semicarbazide-Sensitive Amine Oxidase Activity (SSAO): New Markers of Oxidative Stress in Acute Coronary Syndromes
Muhl L	-	The Interaction of Factor VII Activating Protease (FSAP) with Growth Factors Influences Vascular Cell Proliferation and Migration
Muhl L	-	The Marburg I SNP (G511E) of Factor VII Activating Protease (FSAP), Which Is Linked to Atherothrombosis, Exhibits Diminished Proteolytic Activity
	-	The Factor VII Activating Protease (FSAP) Is an Inhibitor of Neointimal Lesion Formation. Comparison with the Marburg I SNP (G511E) of FSAP
Mühlhofer EM	-	Prevention of Venous Thromboembolism with an Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – in Elective Hip Replacement: A Dose-Ranging Study
Mujovic VM	-	Platelets/Endothelium Interaction and Oxidative Stress in Isolated Guinea-Pig Heart: Focus on L-Arginine/ No System and Superoxide Anion Radical Production
Mukherjee M	-	Plasma Homocysteine and Coronary Artery Disease (CAD) in Asian Indians: An Unlikely Risk Factor
	-	Heritability of Triglyceride and Relationship with Sac-1 Polymorphism in 3'-Untranslated Region (UTR) of Apolipoprotein CIII Gene: Linkage of Apolipoprotein CIII Locus (Chromosome 11 q23) and Association of Variant Allele with Coronary Artery Disease (CAD)
Mukherjee M	-	Adult Non-Twin Sib Concordance Rates for Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Hypertension in Asian Indian Population
	-	Heritability of Quantitative Phenotypes: Lipids, Coagulation, Pro-Inflammatory, Cell Adhesion and Anthropometric Markers in the Presence or Absence of Coronary Artery Disease (CAD) in Parents
	-	Expression of Interleukin-1 (IL-1) Alpha Gene and Circulating Levels of Interleukin-6 (IL-6) and Plasminogen Activator Inhibitor-1 (PAI-1): Preliminary Findings of the Indian Atherosclerosis Research Study (IARS)
	-	Relationship Among Antibody Against Cytomegalovirus (CMV), Plasma Interleukin-6 (IL-6) and Coronary Artery Disease (CAD) – Preliminary Findings of the Indian Atherosclerosis Research Study (IARS)
Mulder AB	-	Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio Test and Implications for Monitoring of Oral Anticoagulant Therapy
Muleo G	-	Fibrinogen Storage Disease with Hypofibrinogenaemia
	-	Factor VIII Inhibitor in a Patient with Mild Haemophilia A
Müller CR	-	Arg485Pro Mutation in the Gamma-Glutamyl Carboxylase Contributes to Three Unrelated German VKCFD Type 1 Patients with Compound Heterozygous Mutations
Müller B	-	Hypothetic Genetic Risk Factors for Preeclampsia or HELLP Syndrome: Probabilities of Risk Factors Present in Fetuses Derived from the Genotypes of the Parents
Muller L	-	Anti-factor V Auto-Antibody after the Use of Recombinant Activated Protein C
Muller DW	-	The Activation of Intracoronary Monocytes and Platelets Correlates with Cardiac Enzyme Levels in Patients Undergoing Coronary Artery Stenting
Muller PJ	-	Resuscitation with Lactated Ringers (LR) vs. Normal Saline (NS) Leads to a Hypercoagulable State in an Uncontrolled Hemorrhagic Shock Swine Model
Müller M	-	Antiphospholipid Antibodies in Children – Reference Values in Healthy Controls and Frequency in Children with aPTT Prolongation, Thrombosis or Stroke
Müller CR	-	Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors
Müller G	-	Follow-Up of Patients with Acute Venous Thromboembolism Treated with Ximelagatran for Prophylaxis of Recurrent Events
Müller CR	-	A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses
Muller-Esterl W	-	First Case of Compound Heterozygous Mutations in the Kininogen Gene Causing Severe High-Molecular-Weight Kininogen Deficiency
Müller-Esterl W	-	Heparin-Binding Protein Increases Vascular Permeability by Bradykinin Release: A Novel Link Between Neutrophils and Vascular Inflammation
Mulloy B	-	Protamine Sulphate Neutralization of Anti-Xa and APTT Activities of Low Molecular Weight Heparin Oligosaccharides
Mumford AD	-	Reduced Expression of ABCA1 and A Novel Missense Mutation That Results in Altered Protein Trafficking Underlie Scott Syndrome
Munari M	-	Cerebral Venous Thrombosis: The Padua Experience
Munday AD	-	Relationship of Lipid Rafts and the Platelet Cytoskeleton
Mundell SJ	-	Regulation of Platelet P2Y₁ and P2Y₁₂ Purinergic Receptor Internalization
Munnix ICA	-	Tissue Factor- and Collagen Triggered Thrombosis in vivo Relies on Platelet-Dependent Thrombin Generation in Both Arterioles and Venules
	-	Roles of Platelet ADP and Gas6 Receptors in Thrombus Stability
Munnix ICA	-	Disclosure of Microdomain Structure and Function in Arterial Thrombi of Heterogeneous Composition
Munnix ICA	-	Inhibition of Protein Kinase C Results in an Altered Thrombus Phenotype with Suppressed Platelet Aggregation and Increased Platelet Procoagulant Activity
Munnix ICA	-	Crucial Role of Glycoprotein VI in Thrombus Formation and Coagulation during Venous and Arterial Thrombosis
Munnix ICA	-	Role of Integrin a2b1 in Thrombus Stabilization and Embolization
Muñoz B	-	Inherited Mucocutaneous Bleeding: Clinical Assessment, Relative Frequency of Diseases and High Prevalence of Bleeders with Normal Laboratory Tests: Prospective Study of 280 Patients and 299 Non Bleeder Controls
Münster AMB	-	Lupus Anticoagulant (LA) is Significantly Associated with Inflammation Among Patients Suspected for Deep Vein Thrombosis (DVT)
Münster H	-	Lupus Anticoagulant (LA) is Significantly Associated with Inflammation Among Patients Suspected for Deep Vein Thrombosis (DVT)
Münster A-MB	-	Effect of Protein C and Activated Protein C on Alveolar Fibrin Deposition and Turnover in a Piglet Model of Septic Shock
Munsterhjelm E	-	Acetaminophen Inhibits Platelet Function Dose-dependently in Volunteers
Muntz J	-	Fondaparinux Combined with Intermittent Pneumatic Compression (IPC) Versus IPC Alone in the Prevention of VTE after Major Abdominal Surgery: Results of the APOLLO Study
Muramatsu S	-	Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents
Murasaki K	-	Advanced Glycation End Products Upregulate Endothelial COX-2 Expression and Induce Aspirin Resistant Thromboxane Synthesis by Platelets
Murasaki K	-	Aspirin-Resistant Thromboxane Biosynthesis in Patients with Coronary Artery Disease; Role of Systemic Inflammation and Glycemic Control
Murata M	-	Individual Variation of Platelet Functions after in vitro Incubation with Aspirin: Assessment of Aspirin Resistance in Healthy Subjects Using PFA-100^®
	-	Hemostatic Effects of Polymerized Albumin Particles Carrying Fibrinogen-g Chain Dodecapeptide as Platelet Substitutes in vitro and in vivo
	-	Hemostatic Effects of Polymerized Albumin Particles Carrying Recombinant Glycoprotein Iba as Platelet Substitutes in vitro and in vivo
	-	Hepatocytes are the Major Site of ADAMTS-13 Expression in Human Liver
Murdoch DL	-	Fibrin D-Dimer, by Three Different Assays, is an Independent Predictor of Future Stroke in Patients With Atrial Fibrillation
Murdoch C	-	Adenovirus Urokinase (uPA) Gene Transfection Mediates Monocyte Fibrinolysis
Murer E	-	24 Hours of Physiologic Hyperglycemia/Hyperinsulinemia Causes Platelet Activation Which Can Be Prevented in Vitro by Wortmannin (W)
Murgi E	-	Central Venous Catheters Related Thrombosis in Hematological Patients
Murphey LJ	-	Angiotensin Receptor 2 Over-Expression in Bradykinin B2 Receptor Knockout Mice Produces Thromboprotection
Murphy A	-	Safety, Immunogenicity, and Efficacy of Recombinant Human Thrombin as a Topical Surgical Hemostat: Integrated Results for a Multi-Surgery Phase 2 Program
	-	A New Double Virus Inactivated 4-Factor Prothrombin Complex Concentrate (4F PCC)
Murray ET	-	Comparison of Coaguchek S INRa with Hospital Laboratory Citrated Plasma INRs – What Is the Truth?
Murray H	-	Plasma Fibrinogen and Viscosity and Risk of Cognitive Decline in Elderly Patients with Vascular Risk Factors or Disease
Murray J	-	A Missense Mutation in Exon 28 (C4120T) of the Von Willebrand Factor Gene is the Cause for Von Willebrand Disease in a Large Amish Pedigree
Murugappan S	-	Molecular Mechanism and Functional Implications of Thrombin-Mediated Tyrosine Phosphorylation of PKCd in Platelets
Murzilli S	-	Polyphenolic Components of Extra Virgin Olive Oil: Effect on Arterial Thrombosis and Bioavailability in Rats
Musial J	-	Complementary Antithrombotic Effects of Aspirin and Clopidogrel Based on Pl^A1/A2 Glycoprotein IIIa Polymorphism
Musia[lstrok] J	-	Aspirin Resistance
Musial J	-	Anti-thrombotic Action of Clopidogrel is More Pronounced in Patients with Coronary Artery Disease Carrying Pl^A2 Allele of Beta3 Integrin
	-	Factor VIII Levels and Blood Coagulation in Patients on Long-Term Oral Anticoagulation (OA)
	-	Kinetics of Thrombin Formation at the Site of Microvascular Injury: Effects of Coagulation Factors and Oral Anticoagulation
Musset D	-	Effect of Age on the Performance of a Diagnostic Strategy Based on Clinical Probability, Spiral CT and Venous Compression Ultrasonography: The ESSEP Study
Musso M	-	Evidences for Vascular Endothelium Damage/Proliferation and Abnormal Neoangiogenesis by Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Interleukin-6 (IL-6) Increased Levels in Sickle Cell Disease
Musso R	-	Evidences for Vascular Endothelium Damage/Proliferation and Abnormal Neoangiogenesis by Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Interleukin-6 (IL-6) Increased Levels in Sickle Cell Disease
	-	Recurrent Venous Thromboembolic Events during Treatment with Combined Oral Contraceptives in Hereditaria Dystrophic Epidermolysis Bullosa
Musso M	-	Recurrent Venous Thromboembolic Events during Treatment with Combined Oral Contraceptives in Hereditaria Dystrophic Epidermolysis Bullosa
Musso R	-	Subcutaneous Concentrated Desmopressin Is Very Effective for Treatment of Menometrorrhagias in Women without Inherited or Acquired Bleeding Disorders
Musso M	-	Subcutaneous Concentrated Desmopressin Is Very Effective for Treatment of Menometrorrhagias in Women without Inherited or Acquired Bleeding Disorders
Musso R	-	Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance
	-	Recurrent Symptomatic Thrombotic Stroke in Patients with Patent Foramen Ovale and Prothrombin A20210 Mutation or FV Leiden as Potential Thrombophilic Risk Factors
Musso M	-	Recurrent Symptomatic Thrombotic Stroke in Patients with Patent Foramen Ovale and Prothrombin A20210 Mutation or FV Leiden as Potential Thrombophilic Risk Factors
Musso A	-	Recurrent Symptomatic Thrombotic Stroke in Patients with Patent Foramen Ovale and Prothrombin A20210 Mutation or FV Leiden as Potential Thrombophilic Risk Factors
Musso R	-	Sickle Cell Disease, Reduced Endothelial Nitric Oxide Synthetase and Total Nitric Oxidase Serum Levels, Abnormal Human Endothelin-1 Release, Vascular Endothelium Suffering and Thromboembolic Risk
	-	First Line Therapy with FEIBA^® for the Intracranial Hemorrhages in Haemophilia Patients with Inhibitors
Musso M	-	First Line Therapy with FEIBA^® for the Intracranial Hemorrhages in Haemophilia Patients with Inhibitors
	-	Sickle Cell Disease, Reduced Endothelial Nitric Oxide Synthetase and Total Nitric Oxidase Serum Levels, Abnormal Human Endothelin-1 Release, Vascular Endothelium Suffering and Thromboembolic Risk
Muszbek L	-	Severe Acquired Factor XIII Deficiency Caused by an Autoantibody against the B Subunit
	-	Factor XIII Levels and Factor XIII a Subunit Val34Leu Polymorphism in Patients with Coronary Sclerosis and Myocardial Infarction
	-	Three Novel Missense Mutations and Their Functional Consequences in Two Severe Inherited Factor X Deficiencies
Muszbek L	-	A Novel Homozygous Mutation (1619delC) in GPIIb Gene Associated with Glanzmann Thrombasthenia, the Decay of GPIIb-mRNA and the Synthesis of a Truncated GPIIb Unable to Form Complex with GPIIIa
Muszbek L	-	Acquired FXIII Deficiency in a Patient with Systemic Lupus Erythematodes: Clinical Presentation and Management
Muszbek L	-	Three Novel Heterozygous Mutations in a Patient with Type II Glanzmann Thrombasthenia
Muszbek L	-	Impaired Healing of Cutaneous Wounds in Factor XIII-Deficient Mice
Mutch NJ	-	Regulation of Model Thrombus Lysis by TAFIa, PAI-1 and a₂-Antiplasmin
	-	A Model Thrombus System for Assessing Thrombolysis
Mutin M	-	Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST Elevation Acute Coronary Syndromes
Mu[zcaron]ík J	-	Project HemIS (Haemophilia – Information System): Multicentric Information System of Patients with Haemophilia
Mycka R	-	Thrombin Generation and Protein C Activity in Patients with Acute Myocardial Infarction Treated with Bivalirudin and Heparin
	-	Thrombin Generation and Protein C Activity in Patients with Acute Myocardial Infarction Treated with Bivalirudin and Heparin
Myers D	-	Oral PAI-1 Inhibitor Decreases Thrombosis Without Anticoagulation in a Rat Stenosis Model of Venous Thrombosis
Myers E	-	Pregnancy-Related Arterial and Venous Thromboembolism in the United States 2000–2001
Myers D	-	Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis
Mykhaylov S	-	Regulation of in vivo Viability of Stored Platelet Concentrates by Platelet P-selectin Exposure and Glycoprotein Ib-alpha Downmodulation
	-	Shear-Induced Platelet Apoptosis
Myles T	-	Molecular Characterization of Plasminogen Activator Inhibitor-1 (PAI-1)/Thrombin Inhibition in the Absence and Presence of Heparin and Vitronectin (VN)
	-	Glycoprotein Iba-Mediated Platelet Adhesion and Aggregation to Immobilized Thrombin under Conditions of Flow
	-	Structural Requirements for the Inhibition of Thrombin by Protein C Inhibitor in the Absence and Presence of Heparin and Thrombomodulin
Myles T	-	Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Regulates Activated Complement C5a in vivo
Mysliwiec M	-	Relationship Between Extrinsic Coagulation Pathway Activation and Metalloproteinase-2/TIMPs System in Hemodialysis Patients
	-	Novel Determinants of Increased Plasma Tissue Factor Level in Maintenance Hemodialysis Patients
	-	Effect of TGN 255, a Novel Intravenous Direct Thrombin Inhibitor, on the Prolongation of ACT in Patients Undergoing Haemodialysis
My[sacute]liwiec M	-	Effect of Oxidative Stress on the Circulating Level of Type IV Collagenases and Their Inhibitors in Hemodialyzed Patients with Cardiovascular Disease
	-	Plasmatic and Urinary Tissue Factor (TF) And Its Inhibitor (TFPI) Do Not Reflect the Activity of Human Chronic Glomerulonephritis
Mysliwiec M	-	Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Stable Angina Pectoris Patients Undergoing Coronary Artery Bypass Grafting (CABG)
	-	Effects of Long-Term Simvastatin Treatment on Some Hemostatic Parameters in Hyperlipidemic Patients with Ischemic Heart Disease
	-	Hepcidin: A Link between Anemia, Inflammation and Liver Function in HD Patients?